47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Sunday, 14 March 2021
CME Symposium 08:30 - 10:00 Auditorium 1
IS1, GMMG Symposium
Chairs: Hartmut Goldschmidt (Germany) Christof Scheid (Germany)
Role of allo-TPX in multiple myeloma 08:30 - 08:43 Nicolaus Kröger (Germany)
Importance of achieving a Minimal Residual Disease Negativity in 08:43 - 08:56 multiple myeloma Stefanie Huhn (Germany)
Role of induction therapy in treatment of multiple myeloma 08:56 - 09:09 Hans Salwender (Germany)
Therapy and prognosis of high-risk multiple myeloma 09:09 - 09:22 Katja Weisel (Germany)
Therapeutic developments for refractory multiple myeloma 09:22 - 09:35 Marc Raab (Germany)
Cellular therapy in multiple myeloma 09:35 - 09:48 Christof Scheid (Germany)
Q&A 09:48 - 10:00
Non-Profit Symposium 08:30 - 10:00 Auditorium 2
IS2, Latest developments in hematopoietic cell transplantation - Sorbonne University (ATERHIT) non-profit symposium
Chairs: Arnon Nagler (Israel) Bipin Savani (United States)
Haplo transplant for AML 08:30 - 08:48 Arnon Nagler (Israel)
Haplo transplant for the elderly 08:48 - 09:06 Didier Blaise (France)
Monoclonal antibodies in ALL 09:06 - 09:24 Eolia Brissot (France)
Monoclonal antibodies in Hodgkin lymphoma 09:24 - 09:42 Ali Bazarbachi (Lebanon)
Page 1 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Allogeneic transplantation after CAR T-cell therapy 09:42 - 10:00 Bipin Savani (United States)
Non-Profit Symposium 08:30 - 10:00 Auditorium 3
IS3, Multiple myeloma in 2021: the IFM global perspective - IFM non-profit symposium
Chairs: Mohamad Mohty (France) Jean-Luc Harousseau (France)
What's new for induction prior to ASCT? 08:30 - 08:52 Philippe Moreau (France)
What's new in the elderly setting? 08:52 - 09:14 Thierry Facon (France)
Monoclonal antibodies for relapse after ASCT 09:14 - 09:36 Mohamad Mohty (France)
Requirements for functional cure in myeloma 09:36 - 09:58 Jean-Luc Harousseau (France)
Non-Profit Symposium 08:30 - 10:00 Auditorium 4
IS4, Dilemma in allogeneic hematopoietic transplantation for myelofibrosis - SFGM- TC non-profit symposium
Chairs: Jacques Olivier Bay (France) Thierry Guillaume (France)
Impact of HSCT in ruxolitinib area 08:30 - 08:50 Marie Robin (France)
Transplantation with an alternative donor: Results and perspectives 08:50 - 09:10 Nicolaus Kröger (Germany)
Liver specificities in myelofibrosis and impact on transplantation 09:10 - 09:30 procedure Audrey Payance (France)
Q&A 09:30 - 10:00
Industrial Theatre 08:30 - 18:45 Industry Theatre
IT1, Kite-Gilead Industry Theatre session
Page 2 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industrial Theatre 08:30 - 18:45 Industry Theatre
IT2, BMS Industry Theatre session
Industrial Theatre 08:30 - 18:45 Industry Theatre
IT3, Novartis Industry Theatre session
Industrial Theatre 08:30 - 18:45 Industry Theatre
IT4, Fresenius Kabi Industry Theatre session
Nurses Group 08:30 - 18:45 On-Demand Library
NG13, Nurses Education Day 1: Care of the vulnerable immunocompromised patients in critical care setting
SARS-CoV-2 vaccines overview Almudena Ramírez (Spain)
Disaster management plan: JACIE recommendations
COVID-19: The EBMT recommendations for management of HCT patients and donors Per Ljungman (Sweden)
Nurses Group 08:30 - 18:45 On-Demand Library
NG14, Nurses Education Day 2: Care of the vulnerable immunocompromised patients in critical care setting
Patient's experience Ruth Tweedie (Spain) Miguel Trapero Veledo (Spain)
Psychologist's point of view
Nurse's perspective
Page 3 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 08:30 - 18:45 On-Demand Library
NG15, Nurses Education Day 3: Care of the vulnerable immunocompromised patients in critical care setting
Managing virtual conversations Lloyd Allen (United Kingdom)
Nurse perspective: Virtual long term follow up for BMT patients Michelle Kenyon (United Kingdom)
Back to the future: Emphasizing our new practices Ibrahim Yakoub-Agha (France)
Lab Technicians Day 08:30 - 18:45 On-Demand Library
LT1, Lab Technicians Day: Specialized cell processing
Bone marrow processing: Techniques and results Boris Calmels (France)
Technical aspects and performance TCRab/CD19 depletion Kasper Westinga (Netherlands)
Donor selection and GMP-compliant manufacturing of virus-specific T- cells Britta Eiz-Vesper (Germany)
Lab Technicians Day 08:30 - 18:45 On-Demand Library
LT2, Lab Technicians Day: Cell product testing, validation and characterization
Quality control assessment of ATMP phenotype and functionality using flow cytometry Willemijn Hobo (Netherlands)
Flow cytometry-based CD34 enumeration Harry Dolstra (Netherlands)
Flow cytometric in-process and quality control for CAR T cell manufacturing Ulrike Köhl (Germany)
Educational 08:30 - 18:45 On-Demand Library
E8, New challenges in infectious complications
Page 4 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
T-cell therapy for infections in SCT patients: An experimental treatment or a real choice for the practice? Patrizia Comoli (Italy)
Infectious complications with new drugs in Hematology Georg Maschmeyer (Germany)
The blood virome of HSCT Recipients: Much more than viremia by CMV, EBV, HH6V and adenovirus Marie-Celine Zanella (Switzerland)
Educational 08:30 - 18:45 On-Demand Library
E9, Allogeneic HSCT in MDS and MPN
Definition of graft failure/relapse after allo-HCT in myelofibrosis Donal McLornan (United Kingdom)
Allogeneic HSCT in patients with therapy-related MDS/AML Marie Robin (France)
The role of maintenance therapy after allogeneic HSCT in MDS Francesco Onida (Italy)
Educational 08:30 - 18:45 On-Demand Library
E10, HSCT in paediatric non-malignant indications
Haplo-identical SCT in hemoglobinopathy: Taking pole position? Josu de la Fuente (United Kingdom)
Mismatched family donors in inherited immune disorders: A new perspective Mary A. Slatter (United Kingdom)
HSCT for inherited bone marrow failure syndromes Cristina Díaz de Heredia (Spain)
Cord blood HSCT for non-malignant diseases in children Vanderson Rocha (Brazil)
Educational 08:30 - 18:45 On-Demand Library
E11, Management of early complications in an ambulatory/outpatient setting
Early infectious complications Jan Styczynski (Poland)
Page 5 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Non-infective complications: GVHD and organ toxicity Gerhard Hildebrandt (United States)
The Hospital Clínic experience Francesc Fernández-Avilés (Spain)
Educational 08:30 - 18:45 On-Demand Library
E12, Steroid-resistant/refractory GVHD
GVHD - what’s in a name? Helene Schoemans (Belgium)
Treatment of SR/R acute GVHD Olaf Penack (Germany)
Treatment of SR/R chronic GVHD Zinaida Peric (Croatia)
New technologies in the approach to GVHD Amin Turki (Germany)
Educational 08:30 - 18:45 On-Demand Library
E13, Allogeneic transplantation from alternative donors
Haploidentical vs unrelated in AML Didier Blaise (France)
Haploidentical vs unrelated in ALL Arnon Nagler (Israel)
Haploidentical vs cord Blood in acute leukaemia Frederic Baron (Belgium)
Working Party Session 08:30 - 18:45 On-Demand Library
ALWP, Acute Leukaemia Working Party Session
Introduction Mohamad Mohty (France)
CAR-T cells in adult ALL Arnon Nagler (Israel)
Transplant in refractory AML: Comparison of the different FLAMSA approaches Mohamad Mohty (France)
Page 6 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
MRD in AML: Where do we stand? Ali Bazarbachi (Lebanon)
PTCy GVHD prophylaxis-quo vadis? Leonido Luznic (United States)
Working Party Session 08:30 - 18:45 On-Demand Library
SAAWP, Severe Aplastic Anaemia Working Party Session
Introduction Régis Peffault de Latour (France)
Registry Report Antonio Risitano (Italy)
RACE – clinical update Antonio Risitano (Italy)
RACE – what we learn on the biology of SAA? Austin Kulakaseraraj (United Kingdom)
Androgens in AA: Myth or reality in 2021? Simona Pagliuca (United States)
GVHD and relapse free survival (GRFS) after HSCT for AA Raynier Devillier (France)
Working Party Session 08:30 - 18:45 On-Demand Library
ADWP, Autoimmune Diseases Working Party Session
Welcome and Update from the EBMT registry Raffaella Greco (Italy)
Introducing the session and speakers Tobias Alexander (Germany)
HSCT for multiple sclerosis: Future directions in patient selection and conditioning regimen Riccardo Saccardi (Italy)
HSCT for systemic sclerosis: Future directions in patient selection and conditioning regimen Dominique Farge (France)
HSCT for Crohn’s disease: future directions in patient selection, mobilization and conditioning regimen Elena Ricart (Spain)
Page 7 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
HSCT for autoimmune diseases: Current aspects on early and late complications Majid Kazmi (United Kingdom)
HSCT for autoimmune diseases: Conditioning regimen and outcomes from the Russian experience Denis Fedorenko (Russian Federation)
Closing remarks Tobias Alexander (Germany)
Working Party Session 08:30 - 18:45 On-Demand Library
CMWP, Chronic Malignancies Working Party Session
Scientific activity of the CMWP Ibrahim Yakoub-Agha (France)
Who and when in the course of disease to transplant? - Myelodysplastic syndromes Ghulam Mufti (United Kingdom)
Who and when in the course of disease to transplant? - Myelofibrosis Donal McLornan (United Kingdom)
Is Chronic Myeloid Leukaemia still an indication for allo-HCT? Yves Chalandon (Switzerland)
Is Chronic Lymphocytic Leukemia still an indication for allo-HCT? Peter Dreger (Germany)
Working Party Session 08:30 - 18:45 On-Demand Library
LWP, Lymphoma Working Party Session
Working Party Session 08:30 - 18:45 On-Demand Library
CTIWP, Cellular Therapy and Immunobiology Working Party Session
Working Party Session 08:30 - 18:45 On-Demand Library
TCWP, Transplant Complications Working Party Session
Page 8 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Working Party Session 08:30 - 18:45 On-Demand Library
IDWP, Infectious Diseases Working Party Session
IDWP update Rafael de la Cámara (Spain)
Current scientific proposals of IDWP Dina Averbuch (Israel)
CMV T-cell immunity monitoring: is it time to incorporate it in clinical practices? Roy Chemaly (United States)
What is new in the field of Gram-negative infections in SCT patients? Dina Averbuch (Israel)
Seasonal human coronaviruses vs SARS-CoV-2 in allogeneic hematopoietic stem cell transplantation Jose Luis Piñana (Spain)
Hepatitis C and hepatitis E in SCT Malgorzata Mikulska (Italy)
Central nervous system (CNS) complications following HSCT Martin Schmidt-Hieber (Germany)
Workshop 08:30 - 18:45 On-Demand Library
W10, Controversies in T-cell NHL
Are we improving first-line therapy in TCL? Eva Domingo Domenech (Spain)
Is HSCT the way forward for PTCL? Norbert Schmitz (Germany)
Insights in CAR-T therapy for T cell Lymphomas Helen Heslop (United States)
Workshop 08:30 - 18:45 On-Demand Library
W11, Key organ manifestations of chronic GVHD
Pulmonary chronic GVHD Hildegard Greinix (Austria)
Ocular cGVHD diagnostics - Practical approach Igor Petricek (Croatia)
Page 9 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Gastrointestinal manifestations of chronic GVHD Daniel Wolff (Germany)
Workshop 08:30 - 18:45 On-Demand Library
W12, Donor HLA assessment and matching for allogeneic HSCT
HLA laboratory perspective and recommendations Pascale Loiseau (France)
Clinical perspective and recommendations Francesca Lorentino (Italy)
Selection of unrelated donors and cord blood units for Hematopoietic Cell Transplantation: Guidelines from NMDP/CIBMTR Stephen Spellman (United States)
Workshop 08:30 - 18:45 On-Demand Library
W13, CARs beyond T cells: A focus on next generation CAR-NK cells
CAR NK cells as an "off the shelf" immunotherapy Ulrike Köhl (Germany)
CARs and ADCC to make off-the-shelf NK cells specific against hematologic malignancies Jeffrey Miller (United States)
Target NKG2D ligands on tumor cells Antonio Pérez-Martínez (Spain)
Workshop 08:30 - 18:45 On-Demand Library
W14, In the absence of a matched-sibling, who's the best alternative allogeneic donor?
A matched unrelated donor Bronwen Shaw (United States)
A haploidentical donor Mi Kwon (Spain)
When to choose cord blood Filippo Milano (United States)
Do we have to challenge our current donor hierarchy for patients with hemoglobinopathies? Selim Corbacioglu (Germany)
Page 10 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 08:30 - 18:45 On-Demand Library
NG16, Cellular therapy update
Update: What’s new? Rose Ellard (United Kingdom)
Guidelines Órla Stewart (United Kingdom)
Nurses Group 08:30 - 18:45 On-Demand Library
NG23, Oral session 2: Abstracts session
Nurses Group 08:30 - 18:45 On-Demand Library
NG17, Care of the nurses
Mindfulness Ana M. Muñoz Cobo (Spain)
Building healthy teams
Tips and tricks for self care Jane Keep (United Kingdom)
Nurses Group 08:30 - 18:45 On-Demand Library
NG18, Non-malignant diseases update
Aplastic anaemia Simon Slade (United Kingdom)
Multiple sclerosis Helen Jessop (United Kingdom)
Sickle cell disease Jean-Hugues Dalle (France)
ITP Maria Luisa Lozano (Spain)
Nurses Group 08:30 - 18:45 On-Demand Library
NG19, Disease update
Page 11 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Acute leukaemia Matthew Fowler (United Kingdom)
Managing lymphoma: What nurses and healthcare professionals need to know Erik Aerts (Switzerland)
Multiple myeloma Maaike de Ruijter (Netherlands)
CML (ITK management) Laura Borg (United Kingdom)
Nurses Group 08:30 - 18:45 On-Demand Library
NG24, Outreach projects
Outreach project: India Veena Paulson (India)
Outreach project India
Outreach project: Colombia Sara Saez Carrasco (Colombia)
Nurses Group 08:30 - 18:45 On-Demand Library
NG20, How do I become an expert?
Conditioning regimen Nicolas Kint (Belgium)
Immunosuppression Tiene Bauters (Belgium)
Vaccinations Bipin Savani (United States)
Nurses Group 08:30 - 18:45 On-Demand Library
NG22, Quality processes in JACIE
Quality indicators for nurses Louise McNamara (United Kingdom)
JACIE: What's new?
Page 12 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
What is the nurse role as JACIE Inspector? Eugenia Trigoso Arjona (Spain)
Nurses Group 08:30 - 18:45 On-Demand Library
NG21, Clinical trials in a transplant setting
Current trials overview Isabel Salcedo (Spain)
Convalescent plasma clinical trials for COVID-19 Rocío Layunta (Spain)
Post transplant relapse Stephanie Heyes (United Kingdom)
Special Session 08:30 - 18:45 On-Demand Library
SS7, Young Ambassadors Session
How build up a career in: Academia Didier Blaise (France)
How build up a career in: In Pharmaceutical Industry Dan Tovar (France)
How build up a career in: In Public domains Eva Hilgenfeld (Germany)
What to avoid when writing a paper Jakob Passweg (Switzerland)
How to write a successful grant Robert Zeiser (Germany)
Introduction to medical statistics Simona Iacobelli (Italy)
Social media in stem cell transplantation and cellular therapy Navneet Majhail (United States)
Special Session 08:30 - 18:45 On-Demand Library
SS8, Social Media Session: Do's and don'ts of the interaction in the social media for the HSCT and cell therapy community
Social media beyond twitter for the HSCT and cell therapy community Navneet Majhail (United States)
Page 13 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Do's and don'ts of interaction in social media: Nurse's perspective Matthew Fowler (United Kingdom)
Do’s and don'ts of interaction in social media: How social media can improve patient outcomes - The patient's perspective Gillian Adams (United Kingdom)
Special Session 08:30 - 18:45 On-Demand Library
SS9, How to get published
BMT: Official journal of the EBMT Hillard Lazarus (United States)
How to get published Mohamad Mohty (France)
Special Session 08:30 - 18:45 On-Demand Library
SS10, HARMONY Project
General Overview of the HARMONY Alliance: Progress, Achievements & Results of HARMONY and HARMONY PLUS projects Jesús Maria Hernández Rivas (Spain)
Envisioned contribution of the EBMT to the HARMONY Alliance Guillermo Sanz Santillana (Spain) Yann Guillevic (Switzerland)
EBMT participation in the HARMONY Alliance Anna Sureda (Spain)
HARMONY & HARMONY PLUS Research Projects / Outcomes definition Lars Bullinger (Germany)
HARMONY Platform Ana Heredia Casanovas (Spain)
Data Management 08:30 - 18:45 On-Demand Library
DM9, Education session 9
Follow up forms - How to get a chronological overview of the patient history and follow up Elena Ferrer Martínez del Peral (Spain)
Page 14 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Data Management 08:30 - 18:45 On-Demand Library
DM5, Education session 5
Hematopoietic Cell Transplantation-Comorbidity Index ‘Sorror Score’ Bronwen Shaw (United States)
Data Management 08:30 - 18:45 On-Demand Library
DM6, Education session 6
Response in Multiple Myeloma Meral Beksac (Turkey)
Quality Management 08:30 - 18:45 On-Demand Library
QM5, Quality Management Oral Abstracts
Abstract 1
Abstract 2
Abstract 3
Abstract 4
Data Management 08:30 - 18:45 On-Demand Library
DM7, Education session 7
Minimal residual disease (MRD) Johannes Schetelig (Germany)
Data Management 08:30 - 18:45 On-Demand Library
DM8, Education session 8
Infectious complications Malgorzata Mikulska (Italy)
Page 15 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Joint Session 08:30 - 18:45 On-Demand Library
JS4, Joint session LABMT
Transplant rates, Trends: WBMT/LABMT 2018 survey Oscar González-Ramella (Mexico)
Financing of HSCT in Latin America Gregorio Jaimovich (Argentina)
Selection, management and follow up of related donors: Overview Nina Worel (Austria)
Selection, management and follow up of related donors: Development of an LABMT consensus Gonzalo Ferini (Argentina)
Haploidentical transplants in Latin America: Experience from Argentina/GATMO in acute lymphoblastic leukemia Ana Basquiera (Argentina)
Haploidentical transplants in Latin America: Experience from Brazil/SBTMO in aplastic anemia Carmen Bonfim (Brazil)
Joint Session 08:30 - 18:45 On-Demand Library
JS5, Joint session WBMT: COVID-19 Vaccination in HSCT
Translating science into survival: mRNA vaccines for cancer and infectious disease Christopher Huber (Germany)
COVID-19 vaccination in HSCT Per Ljungman (Sweden)
Global access to COVID-19 vaccines
Industry Symposium 08:30 - 18:45 On-Demand Library
IS38, CMV management in high-risk patients - Biotest Industry Symposium
Chairs: Fabio Ciceri (Italy)
A scoring system to define patients at high risk for CMV Ibrahim Yakoub-Agha (France)
How to manage those CMV high-risk patients – Case Reports Michele Malagola (Italy)
Page 16 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
The immunological benefits of CMV-specific immunoglobulins Javier Carbone (Italy)
Special Session 08:30 - 18:45 On-Demand Library
SS11, The EBMT for Trainees
Being a Trainee in SCT / Cellular Therapy Nico Gagelmann (Germany) Claire Horgan (United Kingdom) Yasmina Serroukh (Belgium) Yuliya Rogacheva (Russian Federation) Tamar Azikuri (Georgia)
Overview of allogeneic SCT for the trainee: ‘Things I wish I’d known' Helene Schoemans (Belgium)
Establishing a career in SCT/cellular therapy Jordan Gauthier (United States)
Complications for trainees 1: How to manage acute GVHD Zinaida Peric (Croatia)
Complications for trainees 2: How to manage VOD Ivan Moiseev (Russian Federation)
How do I … ? 08:30 - 18:45 On-Demand Library
HDI6, How Do I... manage toxicity in immunosuppressed patients?
Transplant associated TMA Sergio Giralt (United States)
Infectious complication Jan Styczynski (Poland)
Patient, Family Donor Day 09:15 - 10:30 Auditorium 6
PFD1, Patient, Family and Donor Day: Post-transplant care
Chairs: Guy Bouguet (France) Sarah Hutton (United Kingdom)
Welcome 09:15 - 09:30 Bregje Verhoeven (Netherlands) Rafael Duarte (Spain)
Introduction to post-transplant care and GvHD 09:30 - 09:35
Page 17 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
A pathway for Post-Transplant Care 09:35 - 09:50 Fiona Dignan (United Kingdom)
Chronic GVHD: The daily impact 09:50 - 10:05 John Murray (United Kingdom)
Patient's experience with chronic GVHD 10:05 - 10:15
Q&A 10:15 - 10:30
CME Symposium 10:30 - 11:30 Auditorium 1
IS5, Gene Therapies for Inherited and Rare Diseases in 2021: What Will They Mean for Patients? - CME Symposium
Industry Symposium 10:30 - 12:00 Auditorium 2
IS6, What is new in GVHD in 2021? - Sanofi Industry Symposium
Industry Symposium 10:30 - 12:00 Auditorium 3
IS7, AML - Jazz Pharmaceuticals Industry Symposium
Industry Symposium 10:30 - 12:00 Auditorium 5
IS8, Multiple Myeloma - Janssen Industry Symposium
Patient, Family Donor Day 10:45 - 11:45 Auditorium 6
PFD2, Patient, Family and Donor Day: Post-transplant care 2
Chairs: Andrea Linke (Germany) Isabel Salcedo (Spain)
Introduction to post-transplant care and sexuality and fertility 10:45 - 10:50
Patient's experience on post-transplant 10:50 - 11:00
Pediatric and young adults fertility an HSCT 11:00 - 11:15 Mara Andrés Moreno (Spain)
Page 18 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
The case for Psychosexual Therapy in Stem Cell Transplantation 11:15 - 11:30 Caroline Lovett (United Kingdom)
Q&A 11:30 - 11:45
Patient, Family Donor Day 12:00 - 12:35 Auditorium 6
PFD3, Patient, Family and Donor Day: COVID-19
Chairs: Guy Bouguet (France) Natacha Bolaños (Spain)
Panel discussion 12:00 - 12:35 Rafael de la Cámara (Spain) Dennis Heng Ling (Spain)
Industry Symposium 12:30 - 14:00 Auditorium 1
IS9, Survival in NHL: CAR T as the standard of care - Kite-Gilead Industry Symposium
Industry Symposium 12:30 - 14:00 Auditorium 2
IS10, Identifying Invasive Mould Disease in haematology patients - Pfizer Industry Symposium
Industry Symposium 12:30 - 14:00 Auditorium 3
IS11, Updates in Acute and Chronic GvHD - Novartis Industry Symposium
Industry Symposium 12:30 - 14:00 Auditorium 4
IS12, VOD - Jazz Pharmaceuticals Industry Symposium
Page 19 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industry Symposium 12:30 - 14:00 Auditorium 5
IS13, Targeting the immune system in multiple myeloma: CAR T cell therapy and beyond - BMS Industry Symposium
Chairs: Xavier Leleu (France)
Welcome and introduction - Multiple myeloma: understanding the unmet 12:30 - 12:40 need Xavier Leleu (France)
Addressing the unmet need in multiple myeloma: innovative immune 12:40 - 12:58 treatment strategies Niels van de Donk (Netherlands)
Panel discussion 12:58 - 13:03
A novel approach: targeting BCMA with CAR T cell therapy 13:03 - 13:15 Nikhil Munshi (United States)
Panel discussion 13:15 - 13:20
The patient and the process: putting CAR T cell therapy into practice 13:20 - 13:35 Xavier Leleu (France)
Panel discussion and symposium summary 13:35 - 13:45
Live Q&A 13:45 - 14:00
Patient, Family Donor Day 13:30 - 14:30 Auditorium 6
PFD4, Patient, Family and Donor Day: New developments and donor focus
Chairs: Julia Ruiz Pato (Spain) Natacha Bolaños (Spain)
Introduction 13:30 - 13:35
Patient's experience with CAR T 13:35 - 13:45
Could CAR T therapy cure cancer patients? 13:45 - 14:00 Marie Jose Kersten (Netherlands)
HSCT for autoimmune diseases and novel indications 14:00 - 14:15 John Snowden (United Kingdom)
Q&A 14:15 - 14:30
Page 20 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industry Symposium 14:30 - 16:00 Auditorium 1
IS14, Present and future approaches with CAR T cell therapy in B-cell malignancies - BMS Industry Symposium
Chairs: Paolo Corradini (Italy)
Welcome and introduction 14:30 - 14:35 Paolo Corradini (Italy)
Current state of CAR T cell therapy in DLBCL 14:35 - 14:55 Paolo Corradini (Italy)
CAR T cell therapy in FL and CLL: achievements and perspectives 14:55 - 15:15 Guillaume Carton (France)
Future directions of CAR T cell therapy in B-cell malignancies 15:15 - 15:35 Stephan Mielke (Sweden)
Q&A, discussion and closing remarks 15:35 - 16:00
Industry Symposium 14:30 - 16:00 Auditorium 2
IS15, Antifungal Therapy in the era of new leukaemia treatments - Kite-Gilead Industry Symposium
Industry Symposium 14:30 - 16:00 Auditorium 3
IS16, HSCT-TMA - Omeros Industry Symposium
CME Symposium 14:30 - 16:00 Auditorium 4
IS17, Modernizing the Care of CMV in HCT Recipients: Management Updates and Reducing Risks - CME Symposium
Industry Symposium 14:30 - 16:00 Auditorium 5
IS18, Challenges in Relapse/Refractory Multiple Myeloma - Sanofi Industry Symposium
Page 21 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Patient, Family Donor Day 14:45 - 15:40 Auditorium 6
PFD5, Patient, Family and Donor Day: New developments and donor focus 2
Chairs: Lola Manterola (Spain) Gillian Adams (United Kingdom)
Introduction to speakers 14:45 - 14:50
Donor Registry: “A lifesaver”. General and spanish situation 14:50 - 15:05 Juliana Villa (Spain)
Live dialogue: Pediatric transplantation: How does it work? 15:05 - 15:30 Antonio Pérez-Martínez (Spain) Daniel Guerrero (Spain)
Q&A 15:30 - 15:40
Special Session 16:00 - 17:30 Auditorium 6
SS1, Interactive debate on patient engagement in transplantation and cell therapy
Chairs: Bregje Verhoeven (Netherlands) Helene Schoemans (Belgium)
The patient's engagement experience 16:00 - 16:10 Chris Lewis (United Kingdom)
Why consider patient engagement in research 16:10 - 16:25 Sabina De Geest (Switzerland)
Integrating patients in research projects – Practical considerations 16:25 - 16:40 Linda Burns (United States)
Using Patient Reported Outcomes in the clinic – Practical considerations 16:40 - 16:55 Sarah Liptrott (Italy)
Panel discussion - Interactive debate 16:55 - 17:15
Closing comments 17:15 - 17:25 Bregje Verhoeven (Netherlands) Pavel Jindra (Czech Republic)
Industry Symposium 16:30 - 18:00 Auditorium 1
IS19, Cell therapy & survival: An interactive focus on the future - Kite-Gilead Industry Symposium
Page 22 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industry Symposium 16:30 - 18:00 Auditorium 2
IS20, What is the New Evidence in the Era of CMV Prophylaxis? - MSD Industry Symposium
Chairs: Rafael de la Cámara (Spain)
Welcome, and Opening Remarks 16:30 - 16:35 Rafael de la Cámara (Spain)
New evidence for CMV prophylaxis in the post-transplant setting 16:35 - 16:55 Catherine Cordonnier (France)
Viral load kinetics and CMV immunity in the clinical practice 16:55 - 17:15 Miguel-Angel Perales (United States)
Is CMV prophylaxis cost-effective? 17:15 - 17:35 Corrado Girmenia (Italy)
Post-assessment Polling Questions; Open live Q&A 17:35 - 17:40 Rafael de la Cámara (Spain)
Live Q&A and Closing remarks 17:40 - 18:00
Industry Symposium 16:30 - 17:15 Auditorium 3
IS21, New maintenance strategies in AML - BMS Industry Symposium
Chairs: Nicolaus Kröger (Germany)
Welcome and introduction 16:30 - 16:35 Nicolaus Kröger (Germany)
Clinical challenges in the management of AML patients in complete 16:35 - 16:50 remission Norbert Vey (France)
Evolving treatment approaches to prolong complete remission in AML 16:50 - 17:05 Farhad Ravandi (United States)
Panel discussion and Closing remarks 17:05 - 17:15
Industry Symposium 16:30 - 18:00 Auditorium 4
IS22, Nurse Symposium: VOD - Jazz Pharmaceuticals Industry Symposium
Page 23 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industry Symposium 16:30 - 18:00 Auditorium 5
IS23, Calibrating the intensity of GvHD therapy to allow clinical tolerance – a role for ECP Immunomodulation? - Therakos-Mallinckrodt Industry Symposium
General 18:00 - 19:15 Auditorium 1
GS1, Opening Ceremony
Welcome and introduction 18:00 - 18:05 Nicolaus Kröger (Germany)
Welcome and introduction to the conference 18:05 - 18:10 Rafael Duarte (Spain)
Welcome from the Nurses Group 18:10 - 18:14 John Murray (United Kingdom)
EBMT Patient Advocacy Committee: Welcome note 18:14 - 18:18 Bregje Verhoeven (Netherlands)
Honorary Member Awards 2020 18:18 - 18:48 Alejandro Madrigal (United Kingdom) Ernst Holler (Germany) Dietger Niederwieser (Germany) Andrea Bacigalupo (Italy)
Introduction of the Keynote speaker 18:48 - 18:50 Rafael Duarte (Spain)
Keynote lecture - Management of the COVID-19 pandemic: The 18:50 - 19:15 perspective from Madrid-IFEMA Field Hospital Antonio Zapatero (Spain)
Page 24 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Monday, 15 March 2021
Educational 09:15 - 10:30 Auditorium 1
E1, Long-term management of alloHSCT recipients
Chairs: Patrice Chevallier (France) María del Mar Perera Álvarez (Spain)
Survivorship care plans 09:15 - 09:30 Navneet Majhail (United States)
Secondary malignancies 09:30 - 09:45 Christian Koenecke (Germany)
Practical management of long-term organ complications 09:45 - 10:00 Mutlu Arat (Turkey)
Q&A 10:00 - 10:30
How do I … ? 09:15 - 10:30 Auditorium 2
HDI1, How do I... manage AML patients in first remission? - Supported through an unrestricted educational grant by BMS
Chairs: Jordi Esteve (Spain)
Transplant eligible patient 09:15 - 09:40 Christoph Schmid (Germany)
Transplant ineligible patients 09:40 - 10:05
Q&A 10:05 - 10:30
Nurses Group 09:15 - 10:30 Auditorium 3
NG01, Nurses Group Opening Session
Welcome and overview 09:15 - 09:25 John Murray (United Kingdom)
Presentation of the 13th Distinguished Merit Award 09:25 - 09:30 John Murray (United Kingdom)
The extensive role of nurses 09:30 - 10:00 Jose Luis Cobos Serrano (Spain)
Page 25 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Artificial Intelligence in health care 10:00 - 10:30 Sharukh Hashmi (United States)
Cell therapy 09:15 - 10:30 Auditorium 4
CTD1, Cell Therapy Day: How to manage poor mobilizers?
Use of plerixafor in donors 09:15 - 09:35
Microbiota and stem cell mobilization 09:35 - 09:55
Outcome of BM harvested from poor mobilizers 09:55 - 10:10
Q&A 10:10 - 10:30
Transplant and Search Coordinators Day 09:15 - 10:30 Auditorium 5
TSCD1, Transplant and Search Coordinators Day: New HLA Typing Techniques and how they changed the way to transplant
Chairs: Joannis Mytilineos (Germany) Eric Spierings (Netherlands)
Introduction and overview 09:15 - 09:30 Eric Spierings (Netherlands)
Debate: Do we still need Verification Typing (VT) of the donor?
No, rely on initial high resolution typing 09:30 - 09:50 Matthias Stelljes (Germany)
Yes, safety first 09:50 - 10:10 Rachel Pawson (United Kingdom)
Panel discussion 10:10 - 10:30
Psy Day 09:15 - 10:30 Auditorium 6
Psy1, Workshop 1: Survivorship Program
Chairs: Alexandra Carpentier (Spain) Frank Schulz-Kindermann (Germany)
Introduction 09:15 - 09:21 Anna Barata (United States)
Page 26 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Family caregivers, research methods and results with translation 09:21 - 09:39 potential for HCT Karen Syrjala (United States)
Cognitive outcomes on CAR T-cell therapy recipients 09:39 - 09:57 Anna Barata (United States)
Quality of life in childhood cancer survivors and their famílies after end 09:57 - 10:15 of acute treatment Corinna Bergelt (Germany)
Q&A 10:15 - 10:30
Industrial Theatre 09:15 - 18:00 Industry Theatre
IT1, Kite-Gilead Industry Theatre session
Industrial Theatre 09:15 - 18:00 Industry Theatre
IT2, BMS Industry Theatre session
Industrial Theatre 09:15 - 18:00 Industry Theatre
IT3, Novartis Industry Theatre session
Industrial Theatre 09:15 - 18:00 Industry Theatre
IT4, Fresenius Kabi Industry Theatre session
Nurses Group 09:15 - 18:00 On-Demand Library
NG13, Nurses Education Day 1: Care of the vulnerable immunocompromised patients in critical care setting
SARS-CoV-2 vaccines overview Almudena Ramírez (Spain)
Disaster management plan: JACIE recommendations
COVID-19: The EBMT recommendations for management of HCT patients and donors Per Ljungman (Sweden)
Page 27 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 18:00 On-Demand Library
NG14, Nurses Education Day 2: Care of the vulnerable immunocompromised patients in critical care setting
Patient's experience Ruth Tweedie (Spain) Miguel Trapero Veledo (Spain)
Psychologist's point of view
Nurse's perspective
Nurses Group 09:15 - 18:00 On-Demand Library
NG15, Nurses Education Day 3: Care of the vulnerable immunocompromised patients in critical care setting
Managing virtual conversations Lloyd Allen (United Kingdom)
Nurse perspective: Virtual long term follow up for BMT patients Michelle Kenyon (United Kingdom)
Back to the future: Emphasizing our new practices Ibrahim Yakoub-Agha (France)
Lab Technicians Day 09:15 - 18:00 On-Demand Library
LT1, Lab Technicians Day: Specialized cell processing
Bone marrow processing: Techniques and results Boris Calmels (France)
Technical aspects and performance TCRab/CD19 depletion Kasper Westinga (Netherlands)
Donor selection and GMP-compliant manufacturing of virus-specific T- cells Britta Eiz-Vesper (Germany)
Lab Technicians Day 09:15 - 18:00 On-Demand Library
LT2, Lab Technicians Day: Cell product testing, validation and characterization
Quality control assessment of ATMP phenotype and functionality using flow cytometry Willemijn Hobo (Netherlands)
Page 28 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Flow cytometry-based CD34 enumeration Harry Dolstra (Netherlands)
Flow cytometric in-process and quality control for CAR T cell manufacturing Ulrike Köhl (Germany)
Educational 09:15 - 18:00 On-Demand Library
E8, New challenges in infectious complications
T-cell therapy for infections in SCT patients: An experimental treatment or a real choice for the practice? Patrizia Comoli (Italy)
Infectious complications with new drugs in Hematology Georg Maschmeyer (Germany)
The blood virome of HSCT Recipients: Much more than viremia by CMV, EBV, HH6V and adenovirus Marie-Celine Zanella (Switzerland)
Educational 09:15 - 18:00 On-Demand Library
E9, Allogeneic HSCT in MDS and MPN
Definition of graft failure/relapse after allo-HCT in myelofibrosis Donal McLornan (United Kingdom)
Allogeneic HSCT in patients with therapy-related MDS/AML Marie Robin (France)
The role of maintenance therapy after allogeneic HSCT in MDS Francesco Onida (Italy)
Educational 09:15 - 18:00 On-Demand Library
E10, HSCT in paediatric non-malignant indications
Haplo-identical SCT in hemoglobinopathy: Taking pole position? Josu de la Fuente (United Kingdom)
Mismatched family donors in inherited immune disorders: A new perspective Mary A. Slatter (United Kingdom)
HSCT for inherited bone marrow failure syndromes Cristina Díaz de Heredia (Spain)
Page 29 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Cord blood HSCT for non-malignant diseases in children Vanderson Rocha (Brazil)
Educational 09:15 - 18:00 On-Demand Library
E11, Management of early complications in an ambulatory/outpatient setting
Early infectious complications Jan Styczynski (Poland)
Non-infective complications: GVHD and organ toxicity Gerhard Hildebrandt (United States)
The Hospital Clínic experience Francesc Fernández-Avilés (Spain)
Educational 09:15 - 18:00 On-Demand Library
E12, Steroid-resistant/refractory GVHD
GVHD - what’s in a name? Helene Schoemans (Belgium)
Treatment of SR/R acute GVHD Olaf Penack (Germany)
Treatment of SR/R chronic GVHD Zinaida Peric (Croatia)
New technologies in the approach to GVHD Amin Turki (Germany)
Educational 09:15 - 18:00 On-Demand Library
E13, Allogeneic transplantation from alternative donors
Haploidentical vs unrelated in AML Didier Blaise (France)
Haploidentical vs unrelated in ALL Arnon Nagler (Israel)
Haploidentical vs cord Blood in acute leukaemia Frederic Baron (Belgium)
Page 30 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Working Party Session 09:15 - 18:00 On-Demand Library
ALWP, Acute Leukaemia Working Party Session
Introduction Mohamad Mohty (France)
CAR-T cells in adult ALL Arnon Nagler (Israel)
Transplant in refractory AML: Comparison of the different FLAMSA approaches Mohamad Mohty (France)
MRD in AML: Where do we stand? Ali Bazarbachi (Lebanon)
PTCy GVHD prophylaxis-quo vadis? Leonido Luznic (United States)
Working Party Session 09:15 - 18:00 On-Demand Library
SAAWP, Severe Aplastic Anaemia Working Party Session
Introduction Régis Peffault de Latour (France)
Registry Report Antonio Risitano (Italy)
RACE – clinical update Antonio Risitano (Italy)
RACE – what we learn on the biology of SAA? Austin Kulakaseraraj (United Kingdom)
Androgens in AA: Myth or reality in 2021? Simona Pagliuca (United States)
GVHD and relapse free survival (GRFS) after HSCT for AA Raynier Devillier (France)
Working Party Session 09:15 - 18:00 On-Demand Library
ADWP, Autoimmune Diseases Working Party Session
Welcome and Update from the EBMT registry Raffaella Greco (Italy)
Introducing the session and speakers Tobias Alexander (Germany)
Page 31 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
HSCT for multiple sclerosis: Future directions in patient selection and conditioning regimen Riccardo Saccardi (Italy)
HSCT for systemic sclerosis: Future directions in patient selection and conditioning regimen Dominique Farge (France)
HSCT for Crohn’s disease: future directions in patient selection, mobilization and conditioning regimen Elena Ricart (Spain)
HSCT for autoimmune diseases: Current aspects on early and late complications Majid Kazmi (United Kingdom)
HSCT for autoimmune diseases: Conditioning regimen and outcomes from the Russian experience Denis Fedorenko (Russian Federation)
Closing remarks Tobias Alexander (Germany)
Working Party Session 09:15 - 18:00 On-Demand Library
CMWP, Chronic Malignancies Working Party Session
Scientific activity of the CMWP Ibrahim Yakoub-Agha (France)
Who and when in the course of disease to transplant? - Myelodysplastic syndromes Ghulam Mufti (United Kingdom)
Who and when in the course of disease to transplant? - Myelofibrosis Donal McLornan (United Kingdom)
Is Chronic Myeloid Leukaemia still an indication for allo-HCT? Yves Chalandon (Switzerland)
Is Chronic Lymphocytic Leukemia still an indication for allo-HCT? Peter Dreger (Germany)
Working Party Session 09:15 - 18:00 On-Demand Library
LWP, Lymphoma Working Party Session
Page 32 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Working Party Session 09:15 - 18:00 On-Demand Library
CTIWP, Cellular Therapy and Immunobiology Working Party Session
Working Party Session 09:15 - 18:00 On-Demand Library
TCWP, Transplant Complications Working Party Session
Workshop 09:15 - 18:00 On-Demand Library
W10, Controversies in T-cell NHL
Are we improving first-line therapy in TCL? Eva Domingo Domenech (Spain)
Is HSCT the way forward for PTCL? Norbert Schmitz (Germany)
Insights in CAR-T therapy for T cell Lymphomas Helen Heslop (United States)
Workshop 09:15 - 18:00 On-Demand Library
W11, Key organ manifestations of chronic GVHD
Pulmonary chronic GVHD Hildegard Greinix (Austria)
Ocular cGVHD diagnostics - Practical approach Igor Petricek (Croatia)
Gastrointestinal manifestations of chronic GVHD Daniel Wolff (Germany)
Workshop 09:15 - 18:00 On-Demand Library
W12, Donor HLA assessment and matching for allogeneic HSCT
HLA laboratory perspective and recommendations Pascale Loiseau (France)
Clinical perspective and recommendations Francesca Lorentino (Italy)
Page 33 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Selection of unrelated donors and cord blood units for Hematopoietic Cell Transplantation: Guidelines from NMDP/CIBMTR Stephen Spellman (United States)
Workshop 09:15 - 18:00 On-Demand Library
W13, CARs beyond T cells: A focus on next generation CAR-NK cells
CAR NK cells as an "off the shelf" immunotherapy Ulrike Köhl (Germany)
CARs and ADCC to make off-the-shelf NK cells specific against hematologic malignancies Jeffrey Miller (United States)
Target NKG2D ligands on tumor cells Antonio Pérez-Martínez (Spain)
Workshop 09:15 - 18:00 On-Demand Library
W14, In the absence of a matched-sibling, who's the best alternative allogeneic donor?
A matched unrelated donor Bronwen Shaw (United States)
A haploidentical donor Mi Kwon (Spain)
When to choose cord blood Filippo Milano (United States)
Do we have to challenge our current donor hierarchy for patients with hemoglobinopathies? Selim Corbacioglu (Germany)
Nurses Group 09:15 - 18:00 On-Demand Library
NG16, Cellular therapy update
Update: What’s new? Rose Ellard (United Kingdom)
Guidelines Órla Stewart (United Kingdom)
Page 34 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 18:00 On-Demand Library
NG23, Oral session 2: Abstracts session
Nurses Group 09:15 - 18:00 On-Demand Library
NG17, Care of the nurses
Mindfulness Ana M. Muñoz Cobo (Spain)
Building healthy teams
Tips and tricks for self care Jane Keep (United Kingdom)
Nurses Group 09:15 - 18:00 On-Demand Library
NG18, Non-malignant diseases update
Aplastic anaemia Simon Slade (United Kingdom)
Multiple sclerosis Helen Jessop (United Kingdom)
Sickle cell disease Jean-Hugues Dalle (France)
ITP Maria Luisa Lozano (Spain)
Nurses Group 09:15 - 18:00 On-Demand Library
NG19, Disease update
Acute leukaemia Matthew Fowler (United Kingdom)
Managing lymphoma: What nurses and healthcare professionals need to know Erik Aerts (Switzerland)
Multiple myeloma Maaike de Ruijter (Netherlands)
CML (ITK management) Laura Borg (United Kingdom)
Page 35 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Special Session 09:15 - 18:00 On-Demand Library
SS10, HARMONY Project
General Overview of the HARMONY Alliance: Progress, Achievements & Results of HARMONY and HARMONY PLUS projects Jesús Maria Hernández Rivas (Spain)
Envisioned contribution of the EBMT to the HARMONY Alliance Guillermo Sanz Santillana (Spain) Yann Guillevic (Switzerland)
EBMT participation in the HARMONY Alliance Anna Sureda (Spain)
HARMONY & HARMONY PLUS Research Projects / Outcomes definition Lars Bullinger (Germany)
HARMONY Platform Ana Heredia Casanovas (Spain)
Nurses Group 09:15 - 18:00 On-Demand Library
NG24, Outreach projects
Outreach project: India Veena Paulson (India)
Outreach project India
Outreach project: Colombia Sara Saez Carrasco (Colombia)
Data Management 09:15 - 18:00 On-Demand Library
DM9, Education session 9
Follow up forms - How to get a chronological overview of the patient history and follow up Elena Ferrer Martínez del Peral (Spain)
Nurses Group 09:15 - 18:00 On-Demand Library
NG20, How do I become an expert?
Conditioning regimen Nicolas Kint (Belgium)
Page 36 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Immunosuppression Tiene Bauters (Belgium)
Vaccinations Bipin Savani (United States)
Nurses Group 09:15 - 18:00 On-Demand Library
NG22, Quality processes in JACIE
Quality indicators for nurses Louise McNamara (United Kingdom)
JACIE: What's new?
What is the nurse role as JACIE Inspector? Eugenia Trigoso Arjona (Spain)
Data Management 09:15 - 18:00 On-Demand Library
DM5, Education session 5
Hematopoietic Cell Transplantation-Comorbidity Index ‘Sorror Score’ Bronwen Shaw (United States)
Nurses Group 09:15 - 18:00 On-Demand Library
NG21, Clinical trials in a transplant setting
Current trials overview Isabel Salcedo (Spain)
Convalescent plasma clinical trials for COVID-19 Rocío Layunta (Spain)
Post transplant relapse Stephanie Heyes (United Kingdom)
Data Management 09:15 - 18:00 On-Demand Library
DM6, Education session 6
Response in Multiple Myeloma Meral Beksac (Turkey)
Page 37 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Special Session 09:15 - 18:00 On-Demand Library
SS7, Young Ambassadors Session
How build up a career in: Academia Didier Blaise (France)
How build up a career in: In Pharmaceutical Industry Dan Tovar (France)
How build up a career in: In Public domains Eva Hilgenfeld (Germany)
What to avoid when writing a paper Jakob Passweg (Switzerland)
How to write a successful grant Robert Zeiser (Germany)
Introduction to medical statistics Simona Iacobelli (Italy)
Social media in stem cell transplantation and cellular therapy Navneet Majhail (United States)
Quality Management 09:15 - 18:00 On-Demand Library
QM5, Quality Management Oral Abstracts
Abstract 1
Abstract 2
Abstract 3
Abstract 4
Special Session 09:15 - 18:00 On-Demand Library
SS8, Social Media Session: Do's and don'ts of the interaction in the social media for the HSCT and cell therapy community
Social media beyond twitter for the HSCT and cell therapy community Navneet Majhail (United States)
Do's and don'ts of interaction in social media: Nurse's perspective Matthew Fowler (United Kingdom)
Do’s and don'ts of interaction in social media: How social media can improve patient outcomes - The patient's perspective Gillian Adams (United Kingdom)
Page 38 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Data Management 09:15 - 18:00 On-Demand Library
DM7, Education session 7
Minimal residual disease (MRD) Johannes Schetelig (Germany)
Special Session 09:15 - 18:00 On-Demand Library
SS9, How to get published
BMT: Official journal of the EBMT Hillard Lazarus (United States)
How to get published Mohamad Mohty (France)
Data Management 09:15 - 18:00 On-Demand Library
DM8, Education session 8
Infectious complications Malgorzata Mikulska (Italy)
Joint Session 09:15 - 18:00 On-Demand Library
JS4, Joint session LABMT
Transplant rates, Trends: WBMT/LABMT 2018 survey Oscar González-Ramella (Mexico)
Financing of HSCT in Latin America Gregorio Jaimovich (Argentina)
Selection, management and follow up of related donors: Overview Nina Worel (Austria)
Selection, management and follow up of related donors: Development of an LABMT consensus Gonzalo Ferini (Argentina)
Haploidentical transplants in Latin America: Experience from Argentina/GATMO in acute lymphoblastic leukemia Ana Basquiera (Argentina)
Haploidentical transplants in Latin America: Experience from Brazil/SBTMO in aplastic anemia Carmen Bonfim (Brazil)
Page 39 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Joint Session 09:15 - 18:00 On-Demand Library
JS5, Joint session WBMT: COVID-19 Vaccination in HSCT
Translating science into survival: mRNA vaccines for cancer and infectious disease Christopher Huber (Germany)
COVID-19 vaccination in HSCT Per Ljungman (Sweden)
Global access to COVID-19 vaccines
Working Party Session 09:15 - 18:00 On-Demand Library
IDWP, Infectious Diseases Working Party Session
IDWP update Rafael de la Cámara (Spain)
Current scientific proposals of IDWP Dina Averbuch (Israel)
CMV T-cell immunity monitoring: is it time to incorporate it in clinical practices? Roy Chemaly (United States)
What is new in the field of Gram-negative infections in SCT patients? Dina Averbuch (Israel)
Seasonal human coronaviruses vs SARS-CoV-2 in allogeneic hematopoietic stem cell transplantation Jose Luis Piñana (Spain)
Hepatitis C and hepatitis E in SCT Malgorzata Mikulska (Italy)
Central nervous system (CNS) complications following HSCT Martin Schmidt-Hieber (Germany)
Industry Symposium 09:15 - 18:00 On-Demand Library
IS38, CMV management in high-risk patients - Biotest Industry Symposium
Chairs: Fabio Ciceri (Italy)
A scoring system to define patients at high risk for CMV Ibrahim Yakoub-Agha (France)
How to manage those CMV high-risk patients – Case Reports Michele Malagola (Italy)
Page 40 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
The immunological benefits of CMV-specific immunoglobulins Javier Carbone (Italy)
Special Session 09:15 - 18:00 On-Demand Library
SS11, The EBMT for Trainees
Being a Trainee in SCT / Cellular Therapy Nico Gagelmann (Germany) Claire Horgan (United Kingdom) Yasmina Serroukh (Belgium) Yuliya Rogacheva (Russian Federation) Tamar Azikuri (Georgia)
Overview of allogeneic SCT for the trainee: ‘Things I wish I’d known' Helene Schoemans (Belgium)
Establishing a career in SCT/cellular therapy Jordan Gauthier (United States)
Complications for trainees 1: How to manage acute GVHD Zinaida Peric (Croatia)
Complications for trainees 2: How to manage VOD Ivan Moiseev (Russian Federation)
How do I … ? 09:15 - 18:00 On-Demand Library
HDI6, How Do I... manage toxicity in immunosuppressed patients?
Transplant associated TMA Sergio Giralt (United States)
Infectious complication Jan Styczynski (Poland)
Plenary Session 11:00 - 12:15 Auditorium 1
P1, Landscape for CLL management in 2021
Chairs: Peter Dreger (Germany) José García-Marco (Spain)
Dissecting CLL at a single-cell level - Implications for therapy and 11:00 - 11:20 outcome Catherine Wu (United States)
Page 41 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
The broadening landscape of targets and therapeutic options for CLL 11:20 - 11:40 Michael Hallek (Germany)
HSCT and cellular therapy for CLL in 2021 11:40 - 12:00 John Gribben (United Kingdom)
Q&A 12:00 - 12:15
Educational 11:00 - 12:15 Auditorium 2
E2, Plasma cell dyscrasias
Chairs: Ramón García Sanz (Spain) Meral Beksac (Turkey)
Autologous HSCT in patients with light chain amyloidosis 11:00 - 11:20 Stefan Schönland (Germany)
Novel immunotherapies in Multiple Myeloma: Bispecific antibodies and 11:20 - 11:40 Anti-body Drug Hermann Einsele (Germany)
CAR-T cells in patients with multiple myeloma 11:40 - 12:00 Nikhil Munshi (United States)
Q&A 12:00 - 12:15
Nurses Group 11:00 - 12:15 Auditorium 3
NG02, How do I... Understand blood counts?
Chairs: Julia Ruiz Pato (Spain)
Liver function test 11:00 - 11:15 Ignacio Gómez-Centurión (Spain)
Renal function test 11:15 - 11:30 Iván López Torija (Spain)
Full blood counts 11:30 - 11:45 Maria Esther Martínez Muñoz (Spain)
Cross matching 11:45 - 12:00 Josune Zubicaray Salegui (Spain)
Q&A 12:00 - 12:15
Page 42 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Cell therapy 11:00 - 12:15 Auditorium 4
CTD2, Cell Therapy Day: Apheresis
Apheresis in low weight children 11:00 - 11:20 Christian Chabannon (France)
Apheresis collections for hematopoietic cellular therapy manufacturing: 11:20 - 11:40 Not all are created equal Miquel Lozano (Spain)
Role of pre HSCT plasma exchanges for DSA positive recipients 11:40 - 11:55 Douglas Gladstone (United States)
Q&A 11:55 - 12:15
Transplant and Search Coordinators Day 11:00 - 12:15 Auditorium 5
TSCD2, Transplant and Search Coordinators Day: Cold cases - Stem cells to go?
Chairs: Salmah Ahmed (United Kingdom) Anna Sureda (Spain)
Preemptive cryopreservation of stem cells - DKMS perspective 11:00 - 11:20 Deborah Buk (Germany)
Preemptive cryopreservation of stem cells - NMDP perspective 11:20 - 11:40 Steven Devine (United States)
The use of banked products - Clinical perspective 11:40 - 12:00 Annoek Broers (Netherlands)
Q&A 12:00 - 12:15
Psy Day 11:00 - 12:15 Auditorium 6
Psy2, Workshops 2: Donors, the transplant team and COVID-19
Chairs: Philip Alexander (United Kingdom) M. Soledad de Linares Fernández (Spain)
Family donors, who cares? 11:00 - 11:20 Suzanna van Walraven (Netherlands)
Supporting the transplant team 11:20 - 11:40 Alice Polomeni (France)
The psychological impact and management of patients, carers and staff 11:40 - 12:00 during the COVID-19 pandemic: Lessons learnt Troy Chase (United Kingdom)
Page 43 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Q&A 12:00 - 12:15
Industry Symposium 13:00 - 14:00 Auditorium 1
IS24, Updates in CAR-T Cell Therapies - Novartis Industry Symposium
Industry Symposium 13:00 - 14:00 Auditorium 2
IS25, Current Developments in Allogeneic Haematopoietic Stem Cell Transplantation - Medac Industry Symposium
Chairs: Arnon Nagler (Israel) Franco Locatelli (Italy)
Welcome and Introduction 13:00 - 13:05 Arnon Nagler (Israel)
Experience in Haploidentical Stem Cell Transplantation Using Trecondi® 13:05 - 13:20 Fabio Ciceri (Italy)
Trecondi® for Reduced Toxicity Conditioning in Malignant Neoplastic 13:20 - 13:35 Diseases Friedrich Stölzel (Germany)
Trecondi® – The Product of Choice for Myeloablative Conditioning in Non- 13:35 - 13:50 Malignant Disesases Selim Corbacioglu (Germany)
Wrap-Up 13:50 - 13:55 Franco Locatelli (Italy)
Q&A 13:55 - 14:00
Industry Symposium 13:00 - 14:00 Auditorium 3
IS26, Therakos ECP Immunomodulation – Getting the most out of your service - Therakos-Mallinckrodt Industry Symposium
Statistics 13:00 - 13:45 Auditorium 4
Stat1, Statistics Workshop
Chairs: Hein Putter (Netherlands)
Page 44 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Different method to analyse time-dependent covariates: The example of 13:00 - 13:45 GVL Avichai Shimoni (Israel) Ariane Boumendil (France)
Transplant and Search Coordinators Day 13:00 - 14:00 Auditorium 5
TSCD3, Transplant and Search Coordinators Day: Donor Attrition and Backup Strategies
Chairs: Annette Rasche (Germany) Christian Chabannon (France)
Ethics of donation and donor attrition at the search stage 13:00 - 13:15 Bernice Elger (Switzerland)
***URGENT: DONOR CANCELLATION*** 13:15 - 13:30 Juliana Villa (Spain)
Back-up strategy along graft request 13:30 - 13:45 Irina Evseeva (United Kingdom)
Q&A 13:45 - 14:00
Psy Day 13:00 - 14:00 Auditorium 6
Psy3, How do I
Chairs: Elena Valero (Spain) Alice Polomeni (France)
How do I... screen patients along the HCT continuum 13:00 - 13:15 Alex King (United Kingdom)
How do I... address the psycho-oncologists well-being 13:15 - 13:30 Frank Schulz-Kindermann (Germany)
How do I... conduct e-health studies: Integrating educational and 13:30 - 13:45 psychosocial aspects Christian Ochoa (Spain)
Q&A 13:45 - 14:00
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS27, MSD Industry Meet the Expert Lunch 1 - Room MTE1
Page 45 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS28, Jazz Pharmaceuticals Industry Meet the Expert Lunch - Room MTE2
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS29, Pfizer Industry Meet the Expert Lunch - Room MTE3
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS30, Bluebird Bio Industry Meet the Expert Lunch 1 - Room MTE4
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS31, Riemser Meet the Expert Lunch - Room MTE5
Leukemia - 2nd ALLO SCT 13:00 - 13:10 Jürgen Finke (Germany)
General 14:30 - 16:00 Auditorium 1
GS2, Presidential Symposium
Van Bekkum Award - Introduction 14:30 - 14:33 Nicolaus Kröger (Germany)
Van Bekkum Award 14:33 - 14:43
Basic Science Award - Introduction 14:43 - 14:46 Rafael Duarte (Spain)
Basic Science Award 14:46 - 14:56
Top Abstracts 14:56 - 16:00
Nurses Group 14:30 - 16:00 Auditorium 3
NG03, Relapse management
Chairs: Marijke Quaghebeur (Belgium)
Page 46 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Decision-making: Ethical and multidisciplinary team issues 14:30 - 14:50 Hilda Mekelenkamp (Netherlands)
Treatment options after relapse in lymphoma 14:50 - 15:10 Daan Dierickx (Belgium)
Psychological aspects 15:10 - 15:30
Q&A 15:30 - 15:45
Cell therapy 14:30 - 16:00 Auditorium 4
CTD3, Cell Therapy Day: How to manage cell collection and processing during COVID 19
Should we have a backup donor always? 14:30 - 14:50
Cryopreservation in case of unrelated donor 14:50 - 15:10
Cryopreservation in case of related donor 15:10 - 15:25 Boris Calmels (France)
Role of Sars-Cov2 testing for donors in the workup 15:25 - 15:40 Rafael de la Cámara (Spain)
Q&A 15:40 - 16:00
Transplant and Search Coordinators Day 14:30 - 16:00 Auditorium 5
TSCD4, Transplant and Search Coordinators Day: Family Donations
Chairs: Nina Worel (Austria) Suzanna van Walraven (Netherlands)
Children as donors – Psychological aspects 14:30 - 14:50 Galen Switzer (United States)
International Family Donation – How Registries can help 14:50 - 15:10 Ann O'Leary (United Kingdom)
Follow up on related donors – the Swiss solution 15:10 - 15:30 Grazia Nicoloso (Switzerland)
Q&A 15:30 - 15:45
Psy Day 14:30 - 15:30 Auditorium 6
Psy4, Abstract Session
Page 47 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Abstract 1 14:30 - 14:45
Abstract 2 14:45 - 15:00
Abstract 3 15:00 - 15:15
Conclusions and remarks 15:15 - 15:30 Anna Barata (United States)
Special Session 16:30 - 18:00 Auditorium 1
SS2, Global Committee Session: The present place of CAR T-cells in the context of stem cell transplantation throughout the world
Chairs: Norbert-Claude Gorin (France) Nicolaus Kröger (Germany)
Introduction and welcome 16:30 - 16:32 Norbert-Claude Gorin (France)
CAR T-cells and autologous stem cell transplantation: A chinese vision 16:32 - 16:46 He Huang (China)
CAR T-cells and allogeneic stem cell transplantation: A middle East vision 16:46 - 17:00 Ali Bazarbachi (Lebanon)
CAR T-cells and stem cell transplantation: A japanese vision 17:00 - 17:14 Shinichiro Okamoto (Japan)
A new target: CAR T-cells anti IL1 RAP for the treatment of AML? 17:14 - 17:28 Cristophe Ferrand (France)
CAR T-cells and stem cell transplantation in Latin America 17:28 - 17:42 Renato Luis Guerino Cunha (Brazil)
Summing up and conclusion 17:42 - 17:44 Nicolaus Kröger (Germany)
Q&A 17:44 - 18:00
Joint Session 16:30 - 17:30 Auditorium 2
JS1, Joint session KSBMT: Role of ATG in MUD and HLA identical sibling transplantation: Korean and European experience
Page 48 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
How do I … ? 16:30 - 17:45 Auditorium 3
HDI2, How Do I... manage the evolving role of the haematology nurse – lifelong learning with new horizons? - Nurse Session - Supported through an unrestricted educational grant by Janssen
Cell therapy 16:30 - 18:00 Auditorium 4
CTD4, Cell Therapy Day: Point of care manufacturing for Immune Effector Cells based medicinal products
Donor derived CD19 CAR-T cell therapy of relapsed B-ALL post- 16:30 - 16:50 allotransplant
Cytokine-induced memory-like natural killer (CIML NK) cells 16:50 - 17:10
Immunotherapies in Haplo HCT with PTCy 17:10 - 17:25 Nicole Santoro (Italy)
Ex vivo T cell generation to improve Post HCT immune reconstitution 17:25 - 17:40
Q&A 17:40 - 18:00
Joint Session 16:30 - 18:00 Auditorium 5
JS2, Joint session CIBMTR/ASTCT/APBMT: Transplantation and Cell Therapy During Pandemics
Special Session 16:30 - 18:00 Auditorium 6
SS3, COVID 1
Abstract Awards 18:00 - 18:30 Auditorium 1
AA1, Abstracts Awards
Jian-Jian Luan Award - Introduction 18:00 - 18:01 Bertram Glass (Germany)
Jian-Jian Luan Award lecture 18:01 - 18:13
Jon J. van Rood Award - Introduction 18:13 - 18:14 Christian Chabannon (France)
Jon J. van Rood Award lecture 18:14 - 18:26
Page 49 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Best Young Abstracts 18:26 - 18:30 Harry Dolstra (Netherlands)
Meet the Expert 18:00 - 19:00 Meet the Expert rooms
Meet the Expert sessions
Patient selection for CART Cell Therapy - Room MTE1
Current role of HSCT in Acute Promyelocytic Leukemia - Room MTE2 Pau Montesinos (Spain)
Improving results of HSCT in adult ALL - Room MTE3 Josep M. Ribera (Spain)
How to diagnose and manage TA-TMA in 2021 - Room MTE4 Vincent Ho (United States)
The role of allogeneic HSCT in CLL in 2021 - Room MTE5 Peter Dreger (Germany)
Page 50 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Tuesday, 16 March 2021
Quality Management 08:00 - 09:00 Meet the Expert rooms
QM MTE, Quality Management Meet the Expert sessions (pre-registration required)
Risk & Change Management Olga López Villar (Spain) Dieter Klarmann (Germany)
Audits & Document Development and Control Julie Dolva (Norway) Renza Monteleone (Italy)
Adverse events & CAPA Anne Emmett (United Kingdom)
Maintaining the QM program and QM plan Phuong Huynh (Belgium) Nick van Sinderen (Netherlands)
Outcome analysis and benchmarking & Validation and verification Mara Magri (Italy) Kim Orchard (United Kingdom)
Personnel, Training and Competency Sarah Holtby (United Kingdom)
Educational 09:15 - 10:30 Auditorium 1
E3, What's new in the pathophysiology and treatment of patient complications?
Chairs: Francesca Bonifazi (Italy) Gustavo Kusminsky (Argentina)
Updates on early transplant complications - VOD/SOS and TMA 09:15 - 09:30 Vincent Ho (United States)
Regulation of GVHD by promoting tissue tolerance 09:30 - 09:45 Pavan Reddy (United States)
Chronic GVHD 09:45 - 10:00 José Antonio Pérez-Simón (Spain)
Q&A 10:00 - 10:30
Page 51 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Educational 09:15 - 10:30 Auditorium 2
E4, Doubts and evidences in the treatment of Relapsed/Refractory Lymphoid Malignancies
Chairs: Bertram Glass (Germany) Dolores Caballero (Spain)
The case of follicular lymphoma 09:15 - 09:30 Silvia Montoto (United Kingdom)
How to sequence cell-based therapies in Mantle Cell Lymphoma 09:30 - 09:45 Mehdi Hamadani (United States)
The case of Hodgkin's lymphoma 09:45 - 10:00 Paolo Corradini (Italy)
Q&A 10:00 - 10:30
Nurses Group 09:15 - 10:30 Auditorium 3
NG04, GVHD
Chairs: Kathy Goris (Belgium)
Update on treatments: New agents and strategy 09:15 - 09:35
Pulmonary GVHD 09:35 - 09:55 Saskia Bos (Belgium)
Musculoskeletal GVHD 09:55 - 10:15 Jaleel Mohammed (United Kingdom)
Q&A 10:15 - 10:30
Paediatric Day 09:15 - 10:30 Auditorium 4
Paed1, Paediatric Diseases Working Party Session
Chairs: Selim Corbacioglu (Germany) Anita Lawitschka (Austria)
CMV-associated thymus dysfunction independently increase the risk of 09:15 - 09:30 chronic GVHD Katrine Kielsen (Denmark)
Specific CAR-T targets in Pediatric AML 09:30 - 09:45 Tobias Feuchtinger (Germany)
Page 52 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Is there a role for CNS boost with transplant in ALL? 09:45 - 10:00 Anna Marie Ewins (United Kingdom)
Strategies for Bridging anti-malignant treatment with GVHD 10:00 - 10:15 prophylaxis&treatment after alloHSCT Hildegard Greinix (Austria)
Q&A 10:15 - 10:30
Pharmacists Day 09:15 - 10:30 Auditorium 5
Pharm1, Pharmacotherapy in SCT
Chairs: Tiene Bauters (Belgium) Maria Estela Moreno Martínez (Spain)
Current evidence for TDM in HSCT: An overview 09:15 - 09:35 Vera Domingos (Portugal)
Treosulfan-containing regimens for patients with malignant and non- 09:35 - 09:55 malignant disorders Krzysztof Kalwak (Poland)
Individualized treatment in pediatric stem cell transplantation: 09:55 - 10:15 therapeutic drug monitoring and pharmacogenetics Eileen van der Stroep (Netherlands)
Q&A 10:15 - 10:30
Special Session 09:15 - 10:30 Auditorium 6
SS4, EBMT Benchmarking - A key quality improvement tool
Chairs: Carlos Solano (Spain) Eoin McGrath (Spain)
Project update 09:15 - 09:30 John Snowden (United Kingdom)
Methodological aspects of EBMT benchmarking 09:30 - 09:45 Hein Putter (Netherlands)
Results so far 09:45 - 10:00 Riccardo Saccardi (Italy)
Next steps - Gaining confidence 10:00 - 10:15 Kim Orchard (United Kingdom)
Round table: Will benchmarking replace the need for accreditation? 10:15 - 10:30
Page 53 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT1, Kite-Gilead Industry Theatre session
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT2, BMS Industry Theatre session
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT3, Novartis Industry Theatre session
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT4, Fresenius Kabi Industry Theatre session
Nurses Group 09:15 - 17:30 On-Demand Library
NG13, Nurses Education Day 1: Care of the vulnerable immunocompromised patients in critical care setting
SARS-CoV-2 vaccines overview Almudena Ramírez (Spain)
Disaster management plan: JACIE recommendations
COVID-19: The EBMT recommendations for management of HCT patients and donors Per Ljungman (Sweden)
Nurses Group 09:15 - 17:30 On-Demand Library
NG14, Nurses Education Day 2: Care of the vulnerable immunocompromised patients in critical care setting
Patient's experience Ruth Tweedie (Spain) Miguel Trapero Veledo (Spain)
Psychologist's point of view
Nurse's perspective
Page 54 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 17:30 On-Demand Library
NG15, Nurses Education Day 3: Care of the vulnerable immunocompromised patients in critical care setting
Managing virtual conversations Lloyd Allen (United Kingdom)
Nurse perspective: Virtual long term follow up for BMT patients Michelle Kenyon (United Kingdom)
Back to the future: Emphasizing our new practices Ibrahim Yakoub-Agha (France)
Lab Technicians Day 09:15 - 17:30 On-Demand Library
LT1, Lab Technicians Day: Specialized cell processing
Bone marrow processing: Techniques and results Boris Calmels (France)
Technical aspects and performance TCRab/CD19 depletion Kasper Westinga (Netherlands)
Donor selection and GMP-compliant manufacturing of virus-specific T- cells Britta Eiz-Vesper (Germany)
Lab Technicians Day 09:15 - 17:30 On-Demand Library
LT2, Lab Technicians Day: Cell product testing, validation and characterization
Quality control assessment of ATMP phenotype and functionality using flow cytometry Willemijn Hobo (Netherlands)
Flow cytometry-based CD34 enumeration Harry Dolstra (Netherlands)
Flow cytometric in-process and quality control for CAR T cell manufacturing Ulrike Köhl (Germany)
Educational 09:15 - 17:30 On-Demand Library
E8, New challenges in infectious complications
Page 55 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
T-cell therapy for infections in SCT patients: An experimental treatment or a real choice for the practice? Patrizia Comoli (Italy)
Infectious complications with new drugs in Hematology Georg Maschmeyer (Germany)
The blood virome of HSCT Recipients: Much more than viremia by CMV, EBV, HH6V and adenovirus Marie-Celine Zanella (Switzerland)
Educational 09:15 - 17:30 On-Demand Library
E9, Allogeneic HSCT in MDS and MPN
Definition of graft failure/relapse after allo-HCT in myelofibrosis Donal McLornan (United Kingdom)
Allogeneic HSCT in patients with therapy-related MDS/AML Marie Robin (France)
The role of maintenance therapy after allogeneic HSCT in MDS Francesco Onida (Italy)
Educational 09:15 - 17:30 On-Demand Library
E10, HSCT in paediatric non-malignant indications
Haplo-identical SCT in hemoglobinopathy: Taking pole position? Josu de la Fuente (United Kingdom)
Mismatched family donors in inherited immune disorders: A new perspective Mary A. Slatter (United Kingdom)
HSCT for inherited bone marrow failure syndromes Cristina Díaz de Heredia (Spain)
Cord blood HSCT for non-malignant diseases in children Vanderson Rocha (Brazil)
Educational 09:15 - 17:30 On-Demand Library
E11, Management of early complications in an ambulatory/outpatient setting
Early infectious complications Jan Styczynski (Poland)
Page 56 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Non-infective complications: GVHD and organ toxicity Gerhard Hildebrandt (United States)
The Hospital Clínic experience Francesc Fernández-Avilés (Spain)
Educational 09:15 - 17:30 On-Demand Library
E12, Steroid-resistant/refractory GVHD
GVHD - what’s in a name? Helene Schoemans (Belgium)
Treatment of SR/R acute GVHD Olaf Penack (Germany)
Treatment of SR/R chronic GVHD Zinaida Peric (Croatia)
New technologies in the approach to GVHD Amin Turki (Germany)
Educational 09:15 - 17:30 On-Demand Library
E13, Allogeneic transplantation from alternative donors
Haploidentical vs unrelated in AML Didier Blaise (France)
Haploidentical vs unrelated in ALL Arnon Nagler (Israel)
Haploidentical vs cord Blood in acute leukaemia Frederic Baron (Belgium)
Working Party Session 09:15 - 17:30 On-Demand Library
ALWP, Acute Leukaemia Working Party Session
Introduction Mohamad Mohty (France)
CAR-T cells in adult ALL Arnon Nagler (Israel)
Transplant in refractory AML: Comparison of the different FLAMSA approaches Mohamad Mohty (France)
Page 57 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
MRD in AML: Where do we stand? Ali Bazarbachi (Lebanon)
PTCy GVHD prophylaxis-quo vadis? Leonido Luznic (United States)
Working Party Session 09:15 - 17:30 On-Demand Library
SAAWP, Severe Aplastic Anaemia Working Party Session
Introduction Régis Peffault de Latour (France)
Registry Report Antonio Risitano (Italy)
RACE – clinical update Antonio Risitano (Italy)
RACE – what we learn on the biology of SAA? Austin Kulakaseraraj (United Kingdom)
Androgens in AA: Myth or reality in 2021? Simona Pagliuca (United States)
GVHD and relapse free survival (GRFS) after HSCT for AA Raynier Devillier (France)
Working Party Session 09:15 - 17:30 On-Demand Library
ADWP, Autoimmune Diseases Working Party Session
Welcome and Update from the EBMT registry Raffaella Greco (Italy)
Introducing the session and speakers Tobias Alexander (Germany)
HSCT for multiple sclerosis: Future directions in patient selection and conditioning regimen Riccardo Saccardi (Italy)
HSCT for systemic sclerosis: Future directions in patient selection and conditioning regimen Dominique Farge (France)
HSCT for Crohn’s disease: future directions in patient selection, mobilization and conditioning regimen Elena Ricart (Spain)
Page 58 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
HSCT for autoimmune diseases: Current aspects on early and late complications Majid Kazmi (United Kingdom)
HSCT for autoimmune diseases: Conditioning regimen and outcomes from the Russian experience Denis Fedorenko (Russian Federation)
Closing remarks Tobias Alexander (Germany)
Working Party Session 09:15 - 17:30 On-Demand Library
CMWP, Chronic Malignancies Working Party Session
Scientific activity of the CMWP Ibrahim Yakoub-Agha (France)
Who and when in the course of disease to transplant? - Myelodysplastic syndromes Ghulam Mufti (United Kingdom)
Who and when in the course of disease to transplant? - Myelofibrosis Donal McLornan (United Kingdom)
Is Chronic Myeloid Leukaemia still an indication for allo-HCT? Yves Chalandon (Switzerland)
Is Chronic Lymphocytic Leukemia still an indication for allo-HCT? Peter Dreger (Germany)
Working Party Session 09:15 - 17:30 On-Demand Library
LWP, Lymphoma Working Party Session
Working Party Session 09:15 - 17:30 On-Demand Library
CTIWP, Cellular Therapy and Immunobiology Working Party Session
Working Party Session 09:15 - 17:30 On-Demand Library
TCWP, Transplant Complications Working Party Session
Page 59 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Workshop 09:15 - 17:30 On-Demand Library
W10, Controversies in T-cell NHL
Are we improving first-line therapy in TCL? Eva Domingo Domenech (Spain)
Is HSCT the way forward for PTCL? Norbert Schmitz (Germany)
Insights in CAR-T therapy for T cell Lymphomas Helen Heslop (United States)
Workshop 09:15 - 17:30 On-Demand Library
W11, Key organ manifestations of chronic GVHD
Pulmonary chronic GVHD Hildegard Greinix (Austria)
Ocular cGVHD diagnostics - Practical approach Igor Petricek (Croatia)
Gastrointestinal manifestations of chronic GVHD Daniel Wolff (Germany)
Workshop 09:15 - 17:30 On-Demand Library
W12, Donor HLA assessment and matching for allogeneic HSCT
HLA laboratory perspective and recommendations Pascale Loiseau (France)
Clinical perspective and recommendations Francesca Lorentino (Italy)
Selection of unrelated donors and cord blood units for Hematopoietic Cell Transplantation: Guidelines from NMDP/CIBMTR Stephen Spellman (United States)
Workshop 09:15 - 17:30 On-Demand Library
W13, CARs beyond T cells: A focus on next generation CAR-NK cells
CAR NK cells as an "off the shelf" immunotherapy Ulrike Köhl (Germany)
Page 60 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
CARs and ADCC to make off-the-shelf NK cells specific against hematologic malignancies Jeffrey Miller (United States)
Target NKG2D ligands on tumor cells Antonio Pérez-Martínez (Spain)
Workshop 09:15 - 17:30 On-Demand Library
W14, In the absence of a matched-sibling, who's the best alternative allogeneic donor?
A matched unrelated donor Bronwen Shaw (United States)
A haploidentical donor Mi Kwon (Spain)
When to choose cord blood Filippo Milano (United States)
Do we have to challenge our current donor hierarchy for patients with hemoglobinopathies? Selim Corbacioglu (Germany)
Nurses Group 09:15 - 17:30 On-Demand Library
NG16, Cellular therapy update
Update: What’s new? Rose Ellard (United Kingdom)
Guidelines Órla Stewart (United Kingdom)
Nurses Group 09:15 - 17:30 On-Demand Library
NG23, Oral session 2: Abstracts session
Nurses Group 09:15 - 17:30 On-Demand Library
NG17, Care of the nurses
Mindfulness Ana M. Muñoz Cobo (Spain)
Page 61 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Building healthy teams
Tips and tricks for self care Jane Keep (United Kingdom)
Nurses Group 09:15 - 17:30 On-Demand Library
NG18, Non-malignant diseases update
Aplastic anaemia Simon Slade (United Kingdom)
Multiple sclerosis Helen Jessop (United Kingdom)
Sickle cell disease Jean-Hugues Dalle (France)
ITP Maria Luisa Lozano (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG19, Disease update
Acute leukaemia Matthew Fowler (United Kingdom)
Managing lymphoma: What nurses and healthcare professionals need to know Erik Aerts (Switzerland)
Multiple myeloma Maaike de Ruijter (Netherlands)
CML (ITK management) Laura Borg (United Kingdom)
Special Session 09:15 - 17:30 On-Demand Library
SS10, HARMONY Project
General Overview of the HARMONY Alliance: Progress, Achievements & Results of HARMONY and HARMONY PLUS projects Jesús Maria Hernández Rivas (Spain)
Page 62 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Envisioned contribution of the EBMT to the HARMONY Alliance Guillermo Sanz Santillana (Spain) Yann Guillevic (Switzerland)
EBMT participation in the HARMONY Alliance Anna Sureda (Spain)
HARMONY & HARMONY PLUS Research Projects / Outcomes definition Lars Bullinger (Germany)
HARMONY Platform Ana Heredia Casanovas (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG24, Outreach projects
Outreach project: India Veena Paulson (India)
Outreach project India
Outreach project: Colombia Sara Saez Carrasco (Colombia)
Data Management 09:15 - 17:30 On-Demand Library
DM9, Education session 9
Follow up forms - How to get a chronological overview of the patient history and follow up Elena Ferrer Martínez del Peral (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG20, How do I become an expert?
Conditioning regimen Nicolas Kint (Belgium)
Immunosuppression Tiene Bauters (Belgium)
Vaccinations Bipin Savani (United States)
Page 63 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 17:30 On-Demand Library
NG22, Quality processes in JACIE
Quality indicators for nurses Louise McNamara (United Kingdom)
JACIE: What's new?
What is the nurse role as JACIE Inspector? Eugenia Trigoso Arjona (Spain)
Data Management 09:15 - 17:30 On-Demand Library
DM5, Education session 5
Hematopoietic Cell Transplantation-Comorbidity Index ‘Sorror Score’ Bronwen Shaw (United States)
Nurses Group 09:15 - 17:30 On-Demand Library
NG21, Clinical trials in a transplant setting
Current trials overview Isabel Salcedo (Spain)
Convalescent plasma clinical trials for COVID-19 Rocío Layunta (Spain)
Post transplant relapse Stephanie Heyes (United Kingdom)
Data Management 09:15 - 17:30 On-Demand Library
DM6, Education session 6
Response in Multiple Myeloma Meral Beksac (Turkey)
Special Session 09:15 - 17:30 On-Demand Library
SS7, Young Ambassadors Session
How build up a career in: Academia Didier Blaise (France)
Page 64 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
How build up a career in: In Pharmaceutical Industry Dan Tovar (France)
How build up a career in: In Public domains Eva Hilgenfeld (Germany)
What to avoid when writing a paper Jakob Passweg (Switzerland)
How to write a successful grant Robert Zeiser (Germany)
Introduction to medical statistics Simona Iacobelli (Italy)
Social media in stem cell transplantation and cellular therapy Navneet Majhail (United States)
Quality Management 09:15 - 17:30 On-Demand Library
QM5, Quality Management Oral Abstracts
Abstract 1
Abstract 2
Abstract 3
Abstract 4
Special Session 09:15 - 17:30 On-Demand Library
SS8, Social Media Session: Do's and don'ts of the interaction in the social media for the HSCT and cell therapy community
Social media beyond twitter for the HSCT and cell therapy community Navneet Majhail (United States)
Do's and don'ts of interaction in social media: Nurse's perspective Matthew Fowler (United Kingdom)
Do’s and don'ts of interaction in social media: How social media can improve patient outcomes - The patient's perspective Gillian Adams (United Kingdom)
Data Management 09:15 - 17:30 On-Demand Library
DM7, Education session 7
Page 65 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Minimal residual disease (MRD) Johannes Schetelig (Germany)
Special Session 09:15 - 17:30 On-Demand Library
SS9, How to get published
BMT: Official journal of the EBMT Hillard Lazarus (United States)
How to get published Mohamad Mohty (France)
Data Management 09:15 - 17:30 On-Demand Library
DM8, Education session 8
Infectious complications Malgorzata Mikulska (Italy)
Joint Session 09:15 - 17:30 On-Demand Library
JS4, Joint session LABMT
Transplant rates, Trends: WBMT/LABMT 2018 survey Oscar González-Ramella (Mexico)
Financing of HSCT in Latin America Gregorio Jaimovich (Argentina)
Selection, management and follow up of related donors: Overview Nina Worel (Austria)
Selection, management and follow up of related donors: Development of an LABMT consensus Gonzalo Ferini (Argentina)
Haploidentical transplants in Latin America: Experience from Argentina/GATMO in acute lymphoblastic leukemia Ana Basquiera (Argentina)
Haploidentical transplants in Latin America: Experience from Brazil/SBTMO in aplastic anemia Carmen Bonfim (Brazil)
Page 66 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Joint Session 09:15 - 17:30 On-Demand Library
JS5, Joint session WBMT: COVID-19 Vaccination in HSCT
Translating science into survival: mRNA vaccines for cancer and infectious disease Christopher Huber (Germany)
COVID-19 vaccination in HSCT Per Ljungman (Sweden)
Global access to COVID-19 vaccines
Working Party Session 09:15 - 17:30 On-Demand Library
IDWP, Infectious Diseases Working Party Session
IDWP update Rafael de la Cámara (Spain)
Current scientific proposals of IDWP Dina Averbuch (Israel)
CMV T-cell immunity monitoring: is it time to incorporate it in clinical practices? Roy Chemaly (United States)
What is new in the field of Gram-negative infections in SCT patients? Dina Averbuch (Israel)
Seasonal human coronaviruses vs SARS-CoV-2 in allogeneic hematopoietic stem cell transplantation Jose Luis Piñana (Spain)
Hepatitis C and hepatitis E in SCT Malgorzata Mikulska (Italy)
Central nervous system (CNS) complications following HSCT Martin Schmidt-Hieber (Germany)
Industry Symposium 09:15 - 17:30 On-Demand Library
IS38, CMV management in high-risk patients - Biotest Industry Symposium
Chairs: Fabio Ciceri (Italy)
A scoring system to define patients at high risk for CMV Ibrahim Yakoub-Agha (France)
How to manage those CMV high-risk patients – Case Reports Michele Malagola (Italy)
Page 67 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
The immunological benefits of CMV-specific immunoglobulins Javier Carbone (Italy)
Special Session 09:15 - 17:30 On-Demand Library
SS11, The EBMT for Trainees
Being a Trainee in SCT / Cellular Therapy Nico Gagelmann (Germany) Claire Horgan (United Kingdom) Yasmina Serroukh (Belgium) Yuliya Rogacheva (Russian Federation) Tamar Azikuri (Georgia)
Overview of allogeneic SCT for the trainee: ‘Things I wish I’d known' Helene Schoemans (Belgium)
Establishing a career in SCT/cellular therapy Jordan Gauthier (United States)
Complications for trainees 1: How to manage acute GVHD Zinaida Peric (Croatia)
Complications for trainees 2: How to manage VOD Ivan Moiseev (Russian Federation)
How do I … ? 09:15 - 17:30 On-Demand Library
HDI6, How Do I... manage toxicity in immunosuppressed patients?
Transplant associated TMA Sergio Giralt (United States)
Infectious complication Jan Styczynski (Poland)
Educational 11:00 - 12:15 Auditorium 1
E5, Maintenance therapies after HSCT in acute leukaemia
Chairs: Mohamad Mohty (France) Pau Montesinos (Spain)
Novel targeted therapy post-HSCT for ALL 11:00 - 11:15 Eolia Brissot (France)
Page 68 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Novel targeted therapy post-HSCT for AML/MDS 11:15 - 11:30 Gesine Bug (Germany)
T-cell therapies after transplantation 11:30 - 11:45 Fred Falkenburg (Netherlands)
Q&A 11:45 - 12:15
Educational 11:00 - 12:15 Auditorium 2
E6, CAR-T toxicity and management
Chairs: Maria Liz Paciello (Spain) Olaf Penack (Germany)
Cytokine release syndrome 11:00 - 11:15 Susana Rives (Spain)
Neurotoxicity 11:15 - 11:30 Miguel-Angel Perales (United States)
EBMT recommendations 11:30 - 11:45 Patrick Hayden (Ireland)
Q&A 11:45 - 12:15
Nurses Group 11:00 - 12:15 Auditorium 3
NG05, Joint session: Team work in the CAR T-cells setting
Chairs: Caroline Bompoint (France)
Indications and patient selection 11:00 - 11:20 Reuben Benjamin (United Kingdom)
Training workforce 11:20 - 11:40 Ian Hollingsworth (United Kingdom)
Quality of life in caregivers and patients undergoing CAR T therapy 11:40 - 12:00 Anna Barata (United States)
Q&A 12:00 - 12:15
Page 69 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Paediatric Day 11:00 - 12:15 Auditorium 4
Paed2, Inborn Errors Working Party Session
Chairs: Michael Albert (Germany) Benedicte Neven (France)
Antibody-based conditioning in SCID and beyond 11:00 - 11:15 Agnieszka Czechowicz (United States)
Clinical and immunological outcome after HSCT in severe combined 11:15 - 11:30 immune deficiency, a SCETIDE cohort study Arjan Lankester (Netherlands)
A prospective outcome study in profound combined immune deficiency 11:30 - 11:45 Stephan Ehl (Germany)
Advances in stem cell therapy in metachromatic leukodystrophy 11:45 - 12:00 Valeria Calbi (Italy)
Q&A 12:00 - 12:15
Pharmacists Day 11:00 - 12:15 Auditorium 5
Pharm2, Supportive care 1
Chairs: Nick Duncan (United Kingdom) Agnès Bonnin (France)
Drug-drug interactions between antifungals and immunosuppressive 11:00 - 11:20 agents Eline Muilwijk (Netherlands)
Drug interactions with complementary and alternatives herbs and 11:20 - 11:40 medicines Christoph Ritter (Germany)
New developments in the management of steroid-refractory GVHD 11:40 - 12:00 Raakhee Shah (United Kingdom)
Q&A 12:00 - 12:15
Quality Management 11:00 - 12:15 Auditorium 6
QM1, Center Session
Chairs: Isabel Sánchez-Ortega (Spain)
Accreditation Process 11:00 - 11:10 Carla Sánchez (Spain)
Page 70 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Basic quality management concepts 11:10 - 11:20 John Fitzgerald (Ireland)
Lessons learned from first-time inspections and re-accreditation 11:20 - 11:30 inspections Carolina Herranz (Spain)
HSCT QM Book 11:30 - 12:00 Joaquim Vives Armengol (Spain)
Q&A 12:00 - 12:15
Industry Symposium 13:00 - 14:00 Auditorium 2
IS32, Cell Therapy - Janssen Industry Symposium
General 13:00 - 13:50 Auditorium 4
GS3, General Assembly
Chairs: Nicolaus Kröger (Germany)
President's Report 13:00 - 13:10 Nicolaus Kröger (Germany)
Treasurer's Financial Report 13:10 - 13:20 Harry Dolstra (Netherlands)
Secretary's Report 13:20 - 13:30 John Snowden (United Kingdom)
2021 Election results 13:30 - 13:35 John Snowden (United Kingdom)
Outgoing Board members 13:35 - 13:45 Nicolaus Kröger (Germany)
Text chat Q&A 13:45 - 13:50
Statistics 13:00 - 14:00 Auditorium 5
Stat2, Statistical Symposium
Chairs: Liesbeth de Wreede (Netherlands)
Page 71 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Sensitivity Analysis: E-value based on directly adjusted survival 13:00 - 13:25 probabilities Mei-Jie Zhang (United States)
Working with incomplete data: When one-size-fits-all does not fit 13:25 - 13:50 Nicole Erler (Netherlands)
Q&A 13:50 - 14:00
Quality Management 13:00 - 14:00 Auditorium 6
QM2, QMS and new activities in SC Program
Chairs: Carlos Torrico (Spain)
Allogeneic SCT in the COVID era 13:00 - 13:15 Anna Grassi (Italy)
Integration of JACIE Quality Management System and Qualification for IEC 13:15 - 13:30 Helena Munro (United Kingdom)
Investigational Products 13:30 - 13:45 Simon Hack (United Kingdom)
Q&A 13:45 - 14:00
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS33, MSD Industry Meet the Expert Lunch 2 - Room MTE1
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS34, Therakos-Mallinckrodt Industry Meet the Expert Lunch - Room MTE2
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS35, Bluebird Bio Industry Meet the Expert Lunch 2 - Room MTE3
Industry Symposium 13:00 - 14:00 Meet the Expert rooms
IS36, Takeda Industry Meet the Expert Lunch - Room MTE4
Page 72 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
How I treat the high-risk ‘difficult-to-treat’ stem cell transplant 13:00 - 14:00 recipients with CMV infections (including refractory/resistant)
Workshop 14:30 - 15:45 Auditorium 1
W1, Battling acute leukemia relapse after allogeneic HSCT
Chairs: Thomas Cluzeau (France) David Valcárcel Ferreiras (Spain)
CAR T-cells 14:30 - 14:45 Mohamad Mohty (France)
Maintenance strategies after allogeneic HSCT 14:45 - 15:00 Charles Craddock (United Kingdom)
Second allogeneic HSCT 15:00 - 15:15 Bipin Savani (United States)
Q&A 15:15 - 15:45
Workshop 14:30 - 15:45 Auditorium 2
W2, Immune biology and therapy beyond CAR-T cells
Chairs: Harry Dolstra (Netherlands) José M. Moraleda (Spain)
Engineering hematopoietic stem and progenitor cells for gene and 14:30 - 14:45 immunotherapy Hans-Peter Kiem (United States)
Immunobiology of Mesenchymal Stromal Cells in allo- and auto-immune 14:45 - 15:00 disorders Willem Fibbe (Netherlands)
Mesenchymal stromal cells for respiratory distress and other organ 15:00 - 15:15 failure Sergio Querol (Spain)
Q&A 15:15 - 15:45
Nurses Group 14:30 - 15:45 Auditorium 3
NG06, Supportive and palliative care
Chairs: Sandra Schoenfeld (Switzerland)
Page 73 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Meaning centered interventions 14:30 - 14:50
Challenges of decision making - End of life 14:50 - 15:10 Jakob Passweg (Switzerland)
Early integration 15:10 - 15:30 Richard Towers (United Kingdom)
Q&A 15:30 - 15:45
Paediatric Day 14:30 - 15:45 Auditorium 4
Paed3, Paediatric Diseases Oral Session
Pharmacists Day 14:30 - 15:45 Auditorium 5
Pharm3, Supportive care 2
Chairs: Vera Domingos (Portugal) Vera Pires (Portugal)
What's new in antifungals? 14:30 - 14:50 Rodrigo Martino (Spain)
Chemotherapy Induced Nausea and Vomiting 14:50 - 15:10 Sumantha Gabriel (United Kingdom)
Nutrition strategies in Hematopoietic Stem Cell Transplantation 15:10 - 15:30 Hartmut Bertz (Germany)
Q&A 15:30 - 15:45
Quality Management 14:30 - 15:45 Auditorium 6
QM3, Draft 8th Edition of the STD
Chairs: Riccardo Saccardi (Italy)
Clinical standards 14:30 - 14:42 Kim Orchard (United Kingdom)
Collections Standards 14:42 - 14:54 Nina Worel (Austria)
Processing Standards 14:54 - 15:06 Ivan van Riet (Belgium)
Page 74 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Quality Management Standards 15:06 - 15:18 Simon Hack (United Kingdom)
Immune Effector Cells Standards 15:18 - 15:30 Riccardo Saccardi (Italy)
Q&A 15:30 - 15:45
Plenary Session 16:15 - 17:30 Auditorium 1
P2, Artificial Intelligence approaching Hemato-oncology and HSCT
Chairs: Rafael Duarte (Spain) Myriam Labopin (France)
Basic concepts, applications, and limitations of Machine Learning: A 16:15 - 16:30 primer for hematologists Roni Shouval (United States)
Artificial Intelligence in Hematology 16:30 - 16:45 Grzegorz Basak (Poland)
Artificial Intelligence to support clinical decision making on infections in 16:45 - 17:00 Hematology Carolina García-Vidal (Spain)
The role of technology and Artificial Intelligence in GVHD 17:00 - 17:15 Sharukh Hashmi (United States)
Q&A 17:15 - 17:30
Workshop 16:15 - 17:30 Auditorium 2
W3, Autoimmune diseases
Chairs: Raffaella Greco (Italy) Montserrat Rovira (Spain)
Immunological basis of HSCT in autoimmune disorders 16:15 - 16:30 Paolo Muraro (United Kingdom)
Stem cells in System Sclerosis: Clinical experience and translational 16:30 - 16:45 relevance Nicoletta Del Papa (Italy)
Autologous HSCT as a treatment for autoimmune disease of the nervous 16:45 - 17:00 system Harry Atkins (Canada)
Q&A 17:00 - 17:30
Page 75 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 16:15 - 17:30 Auditorium 3
NG07, Infections
Chairs: Daphna Hutt (Israel)
How to find a fungal infection 16:15 - 16:30 Toine Mercier (Belgium)
CMV 16:30 - 16:45 Patrice Ceballos (France)
Polyoma virus 16:45 - 17:00 Marta Canesi (Italy)
Nursing leadership in antimicrobial stewardship interventions 17:00 - 17:15
Q&A 17:15 - 17:30
Paediatric Day 16:15 - 17:30 Auditorium 4
Paed4, Inborn Errors Oral Session
Pharmacists Day 16:15 - 17:30 Auditorium 5
Pharm4, Pharmaceutical Research in HSCT
Chairs: Claudia Langebrake (Germany) Tiene Bauters (Belgium)
Abstract 1 16:15 - 16:25
Abstract 2 16:25 - 16:35
Abstract 3 16:35 - 16:45
Pharmaceutical Research in HSCT 16:45 - 17:15 Rick Admiraal (Netherlands)
Discussion 17:15 - 17:30
Quality Management 16:15 - 17:30 Auditorium 6
QM4, Inspectors Session
Chairs: Tuula Rintala (United Kingdom)
Page 76 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
JACIE Activity Report & Update / Volunteers JACIE´s most important 16:15 - 16:25 resource Raquel Espada (Spain) Anna Pasztor (Spain)
Inspection team: Roles 16:25 - 16:35 Mara Magri (Italy) Nick van Sinderen (Netherlands)
How to prepare the JACIE Inspection Report? 16:35 - 16:45 Renza Monteleone (Italy) Esther Zafra (Spain)
Most frequent difficulties faced by JACIE Report Assessors 16:45 - 16:55 Carolina Herranz (Spain) Raquel Espada (Spain)
Post Inspection Phase (Assessing CAPA) and Post Accreditation (Interim 16:55 - 17:05 Audit) Richard Olaussen (Norway) Carla Sánchez (Spain)
"Never dismiss a near miss" 17:05 - 17:15 Yiskah Simons (Saudi Arabia)
Q&A 17:15 - 17:30
Meet the Expert 17:30 - 18:30 Meet the Expert rooms
Meet the Expert sessions
How to modulate the microbiome in HSCT - Room MTE1
Gene therapy for inborn errors ´come of age´ in 2021 - Room MTE2
What changes in conditioning regimens we should implement in 2021? - Room MTE3
Update on biomarkers for GVHD - Room MTE4 Kirk Schultz (Canada)
TBD - Room MTE5
Page 77 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Wednesday, 17 March 2021
Workshop 09:15 - 10:30 Auditorium 1
W4, The expanding field of cellular therapies in inborn errors of immunity (IEI)
Chairs: Arjan Lankester (Netherlands) Cristina Díaz de Heredia (Spain)
Curative options in X-CGD: HCT or gene therapy 09:15 - 09:30 Tayfun Gungor (Switzerland)
HSCT in monogenic autoimmune disorders 09:30 - 09:45 Eleonora Gambineri (Italy)
Challenges of HSCT in adult IEI patients 09:45 - 10:00 Emma Morris (United Kingdom)
Advances in gene editing to treat non-SCID IEI 10:00 - 10:15 Alessandro Aiuti (Italy)
Q&A 10:15 - 10:30
Workshop 09:15 - 10:30 Auditorium 2
W5, Transplantation and bone marrow failure in 2021
Chairs: Béatrice Drexler (Switzerland) Lucrecia Yañez (Spain)
Up-front transplantation in aplastic anemia: Where are we? 09:15 - 09:30 Jean-Hugues Dalle (France)
Haploidentical HSCT and idiopathic aplastic anaemia 09:30 - 09:45 Amy DeZern (United States)
Haploidentical HSCT in Fanconi anaemia 09:45 - 10:00 Carmen Bonfim (Brazil)
Blackfan Diamond anaemia and HSCT 10:00 - 10:15 Brigitte Strahm (Germany)
Q&A 10:15 - 10:30
Page 78 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 10:30 Auditorium 3
NG08, How do I manage... Isolation practices and patient and donors preparation?
Chairs: Janet Baker (United Kingdom)
Evidence for Isolation 09:15 - 09:30 Iris Agreiter (Ireland)
Evidence against Isolation 09:30 - 09:45 Cristina Gallego (Spain)
Hematopoietic Transplant patient's preparation 09:45 - 10:00 Manuela Salinero (Spain)
Donor work up 10:00 - 10:15 Annika Kisch (Sweden)
Q&A 10:15 - 10:30
How do I … ? 09:15 - 10:30 Auditorium 4
HDI3, How Do I... Adapt my treatment approach for high risk GvHD patients? - Supported through an unrestricted educational grant by Therakos-Mallinckrodt
Chairs: Daniel Wolff (Germany)
Role of biomarker 09:15 - 09:40 Francis Ayuk (Germany)
Role of microbiome 09:40 - 10:05 Henrik Sengeløv (Denmark)
Q&A 10:05 - 10:30
Data Management 09:15 - 10:30 Auditorium 5
DM1, Education session 1 - Discussion forum: Cellular therapy
Chairs: Lucas Stolarczyk (United Kingdom)
Toxicities after CART: pathology clinical manifestations and grading 09:15 - 09:35 Jürgen Kuball (Netherlands)
Toxicities after CART: treatment and prognostic factors 09:35 - 10:00 Álvaro Urbano-Ispizua (Spain)
Page 79 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Discussion forum - Cellular therapy Q&A 10:00 - 10:30 Chiara Bonini (Italy) Lawrence Vermeir (United Kingdom) Jürgen Kuball (Netherlands) Álvaro Urbano-Ispizua (Spain)
Multi-stakeholder Forum on Innovative Cellular Therapies 09:15 - 10:30 Auditorium 6
MSF1, Multi-stakeholder Forum on Innovative Cellular Therapies - Session 1
Chairs: Rafael Duarte (Spain)
Real-world regulatory issues in the implementation of Advanced 09:15 - 09:30 Therapies Teresa Chavarria (Spain)
Regulatory issues in a pandemic: The COVID-19 experience 09:30 - 09:45 Cesar Hernandez (Spain)
The development of new ATMPs from an academic perspective: Hurdles 09:45 - 10:00 and opportunities Collin de Haar (Netherlands)
An EU perspective on Health Technology Assessment 10:00 - 10:15 Leonor Varela (Spain)
Q&A 10:15 - 10:30
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT1, Kite-Gilead Industry Theatre session
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT2, BMS Industry Theatre session
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT3, Novartis Industry Theatre session
Page 80 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Industrial Theatre 09:15 - 17:30 Industry Theatre
IT4, Fresenius Kabi Industry Theatre session
Nurses Group 09:15 - 17:30 On-Demand Library
NG13, Nurses Education Day 1: Care of the vulnerable immunocompromised patients in critical care setting
SARS-CoV-2 vaccines overview Almudena Ramírez (Spain)
Disaster management plan: JACIE recommendations
COVID-19: The EBMT recommendations for management of HCT patients and donors Per Ljungman (Sweden)
Nurses Group 09:15 - 17:30 On-Demand Library
NG14, Nurses Education Day 2: Care of the vulnerable immunocompromised patients in critical care setting
Patient's experience Ruth Tweedie (Spain) Miguel Trapero Veledo (Spain)
Psychologist's point of view
Nurse's perspective
Nurses Group 09:15 - 17:30 On-Demand Library
NG15, Nurses Education Day 3: Care of the vulnerable immunocompromised patients in critical care setting
Managing virtual conversations Lloyd Allen (United Kingdom)
Nurse perspective: Virtual long term follow up for BMT patients Michelle Kenyon (United Kingdom)
Back to the future: Emphasizing our new practices Ibrahim Yakoub-Agha (France)
Page 81 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Lab Technicians Day 09:15 - 17:30 On-Demand Library
LT1, Lab Technicians Day: Specialized cell processing
Bone marrow processing: Techniques and results Boris Calmels (France)
Technical aspects and performance TCRab/CD19 depletion Kasper Westinga (Netherlands)
Donor selection and GMP-compliant manufacturing of virus-specific T- cells Britta Eiz-Vesper (Germany)
Lab Technicians Day 09:15 - 17:30 On-Demand Library
LT2, Lab Technicians Day: Cell product testing, validation and characterization
Quality control assessment of ATMP phenotype and functionality using flow cytometry Willemijn Hobo (Netherlands)
Flow cytometry-based CD34 enumeration Harry Dolstra (Netherlands)
Flow cytometric in-process and quality control for CAR T cell manufacturing Ulrike Köhl (Germany)
Educational 09:15 - 17:30 On-Demand Library
E8, New challenges in infectious complications
T-cell therapy for infections in SCT patients: An experimental treatment or a real choice for the practice? Patrizia Comoli (Italy)
Infectious complications with new drugs in Hematology Georg Maschmeyer (Germany)
The blood virome of HSCT Recipients: Much more than viremia by CMV, EBV, HH6V and adenovirus Marie-Celine Zanella (Switzerland)
Educational 09:15 - 17:30 On-Demand Library
E9, Allogeneic HSCT in MDS and MPN
Page 82 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Definition of graft failure/relapse after allo-HCT in myelofibrosis Donal McLornan (United Kingdom)
Allogeneic HSCT in patients with therapy-related MDS/AML Marie Robin (France)
The role of maintenance therapy after allogeneic HSCT in MDS Francesco Onida (Italy)
Educational 09:15 - 17:30 On-Demand Library
E10, HSCT in paediatric non-malignant indications
Haplo-identical SCT in hemoglobinopathy: Taking pole position? Josu de la Fuente (United Kingdom)
Mismatched family donors in inherited immune disorders: A new perspective Mary A. Slatter (United Kingdom)
HSCT for inherited bone marrow failure syndromes Cristina Díaz de Heredia (Spain)
Cord blood HSCT for non-malignant diseases in children Vanderson Rocha (Brazil)
Educational 09:15 - 17:30 On-Demand Library
E11, Management of early complications in an ambulatory/outpatient setting
Early infectious complications Jan Styczynski (Poland)
Non-infective complications: GVHD and organ toxicity Gerhard Hildebrandt (United States)
The Hospital Clínic experience Francesc Fernández-Avilés (Spain)
Educational 09:15 - 17:30 On-Demand Library
E12, Steroid-resistant/refractory GVHD
GVHD - what’s in a name? Helene Schoemans (Belgium)
Treatment of SR/R acute GVHD Olaf Penack (Germany)
Page 83 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Treatment of SR/R chronic GVHD Zinaida Peric (Croatia)
New technologies in the approach to GVHD Amin Turki (Germany)
Educational 09:15 - 17:30 On-Demand Library
E13, Allogeneic transplantation from alternative donors
Haploidentical vs unrelated in AML Didier Blaise (France)
Haploidentical vs unrelated in ALL Arnon Nagler (Israel)
Haploidentical vs cord Blood in acute leukaemia Frederic Baron (Belgium)
Working Party Session 09:15 - 17:30 On-Demand Library
ALWP, Acute Leukaemia Working Party Session
Introduction Mohamad Mohty (France)
CAR-T cells in adult ALL Arnon Nagler (Israel)
Transplant in refractory AML: Comparison of the different FLAMSA approaches Mohamad Mohty (France)
MRD in AML: Where do we stand? Ali Bazarbachi (Lebanon)
PTCy GVHD prophylaxis-quo vadis? Leonido Luznic (United States)
Working Party Session 09:15 - 17:30 On-Demand Library
SAAWP, Severe Aplastic Anaemia Working Party Session
Introduction Régis Peffault de Latour (France)
Registry Report Antonio Risitano (Italy)
Page 84 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
RACE – clinical update Antonio Risitano (Italy)
RACE – what we learn on the biology of SAA? Austin Kulakaseraraj (United Kingdom)
Androgens in AA: Myth or reality in 2021? Simona Pagliuca (United States)
GVHD and relapse free survival (GRFS) after HSCT for AA Raynier Devillier (France)
Working Party Session 09:15 - 17:30 On-Demand Library
ADWP, Autoimmune Diseases Working Party Session
Welcome and Update from the EBMT registry Raffaella Greco (Italy)
Introducing the session and speakers Tobias Alexander (Germany)
HSCT for multiple sclerosis: Future directions in patient selection and conditioning regimen Riccardo Saccardi (Italy)
HSCT for systemic sclerosis: Future directions in patient selection and conditioning regimen Dominique Farge (France)
HSCT for Crohn’s disease: future directions in patient selection, mobilization and conditioning regimen Elena Ricart (Spain)
HSCT for autoimmune diseases: Current aspects on early and late complications Majid Kazmi (United Kingdom)
HSCT for autoimmune diseases: Conditioning regimen and outcomes from the Russian experience Denis Fedorenko (Russian Federation)
Closing remarks Tobias Alexander (Germany)
Working Party Session 09:15 - 17:30 On-Demand Library
CMWP, Chronic Malignancies Working Party Session
Scientific activity of the CMWP Ibrahim Yakoub-Agha (France)
Page 85 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Who and when in the course of disease to transplant? - Myelodysplastic syndromes Ghulam Mufti (United Kingdom)
Who and when in the course of disease to transplant? - Myelofibrosis Donal McLornan (United Kingdom)
Is Chronic Myeloid Leukaemia still an indication for allo-HCT? Yves Chalandon (Switzerland)
Is Chronic Lymphocytic Leukemia still an indication for allo-HCT? Peter Dreger (Germany)
Working Party Session 09:15 - 17:30 On-Demand Library
LWP, Lymphoma Working Party Session
Working Party Session 09:15 - 17:30 On-Demand Library
CTIWP, Cellular Therapy and Immunobiology Working Party Session
Working Party Session 09:15 - 17:30 On-Demand Library
TCWP, Transplant Complications Working Party Session
Workshop 09:15 - 17:30 On-Demand Library
W10, Controversies in T-cell NHL
Are we improving first-line therapy in TCL? Eva Domingo Domenech (Spain)
Is HSCT the way forward for PTCL? Norbert Schmitz (Germany)
Insights in CAR-T therapy for T cell Lymphomas Helen Heslop (United States)
Workshop 09:15 - 17:30 On-Demand Library
W11, Key organ manifestations of chronic GVHD
Page 86 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Pulmonary chronic GVHD Hildegard Greinix (Austria)
Ocular cGVHD diagnostics - Practical approach Igor Petricek (Croatia)
Gastrointestinal manifestations of chronic GVHD Daniel Wolff (Germany)
Workshop 09:15 - 17:30 On-Demand Library
W12, Donor HLA assessment and matching for allogeneic HSCT
HLA laboratory perspective and recommendations Pascale Loiseau (France)
Clinical perspective and recommendations Francesca Lorentino (Italy)
Selection of unrelated donors and cord blood units for Hematopoietic Cell Transplantation: Guidelines from NMDP/CIBMTR Stephen Spellman (United States)
Workshop 09:15 - 17:30 On-Demand Library
W13, CARs beyond T cells: A focus on next generation CAR-NK cells
CAR NK cells as an "off the shelf" immunotherapy Ulrike Köhl (Germany)
CARs and ADCC to make off-the-shelf NK cells specific against hematologic malignancies Jeffrey Miller (United States)
Target NKG2D ligands on tumor cells Antonio Pérez-Martínez (Spain)
Workshop 09:15 - 17:30 On-Demand Library
W14, In the absence of a matched-sibling, who's the best alternative allogeneic donor?
A matched unrelated donor Bronwen Shaw (United States)
A haploidentical donor Mi Kwon (Spain)
Page 87 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
When to choose cord blood Filippo Milano (United States)
Do we have to challenge our current donor hierarchy for patients with hemoglobinopathies? Selim Corbacioglu (Germany)
Nurses Group 09:15 - 17:30 On-Demand Library
NG16, Cellular therapy update
Update: What’s new? Rose Ellard (United Kingdom)
Guidelines Órla Stewart (United Kingdom)
Nurses Group 09:15 - 17:30 On-Demand Library
NG23, Oral session 2: Abstracts session
Nurses Group 09:15 - 17:30 On-Demand Library
NG17, Care of the nurses
Mindfulness Ana M. Muñoz Cobo (Spain)
Building healthy teams
Tips and tricks for self care Jane Keep (United Kingdom)
Nurses Group 09:15 - 17:30 On-Demand Library
NG18, Non-malignant diseases update
Aplastic anaemia Simon Slade (United Kingdom)
Multiple sclerosis Helen Jessop (United Kingdom)
Sickle cell disease Jean-Hugues Dalle (France)
Page 88 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
ITP Maria Luisa Lozano (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG19, Disease update
Acute leukaemia Matthew Fowler (United Kingdom)
Managing lymphoma: What nurses and healthcare professionals need to know Erik Aerts (Switzerland)
Multiple myeloma Maaike de Ruijter (Netherlands)
CML (ITK management) Laura Borg (United Kingdom)
Special Session 09:15 - 17:30 On-Demand Library
SS10, HARMONY Project
General Overview of the HARMONY Alliance: Progress, Achievements & Results of HARMONY and HARMONY PLUS projects Jesús Maria Hernández Rivas (Spain)
Envisioned contribution of the EBMT to the HARMONY Alliance Guillermo Sanz Santillana (Spain) Yann Guillevic (Switzerland)
EBMT participation in the HARMONY Alliance Anna Sureda (Spain)
HARMONY & HARMONY PLUS Research Projects / Outcomes definition Lars Bullinger (Germany)
HARMONY Platform Ana Heredia Casanovas (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG24, Outreach projects
Outreach project: India Veena Paulson (India)
Page 89 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Outreach project India
Outreach project: Colombia Sara Saez Carrasco (Colombia)
Data Management 09:15 - 17:30 On-Demand Library
DM9, Education session 9
Follow up forms - How to get a chronological overview of the patient history and follow up Elena Ferrer Martínez del Peral (Spain)
Nurses Group 09:15 - 17:30 On-Demand Library
NG20, How do I become an expert?
Conditioning regimen Nicolas Kint (Belgium)
Immunosuppression Tiene Bauters (Belgium)
Vaccinations Bipin Savani (United States)
Nurses Group 09:15 - 17:30 On-Demand Library
NG22, Quality processes in JACIE
Quality indicators for nurses Louise McNamara (United Kingdom)
JACIE: What's new?
What is the nurse role as JACIE Inspector? Eugenia Trigoso Arjona (Spain)
Data Management 09:15 - 17:30 On-Demand Library
DM5, Education session 5
Hematopoietic Cell Transplantation-Comorbidity Index ‘Sorror Score’ Bronwen Shaw (United States)
Page 90 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 09:15 - 17:30 On-Demand Library
NG21, Clinical trials in a transplant setting
Current trials overview 09:15 - 09:40 Isabel Salcedo (Spain)
Convalescent plasma clinical trials for COVID-19 09:40 - 10:05 Rocío Layunta (Spain)
Post transplant relapse 10:05 - 10:30 Stephanie Heyes (United Kingdom)
Data Management 09:15 - 17:30 On-Demand Library
DM6, Education session 6
Response in Multiple Myeloma Meral Beksac (Turkey)
Special Session 09:15 - 17:30 On-Demand Library
SS7, Young Ambassadors Session
How build up a career in: Academia Didier Blaise (France)
How build up a career in: In Pharmaceutical Industry Dan Tovar (France)
How build up a career in: In Public domains Eva Hilgenfeld (Germany)
What to avoid when writing a paper Jakob Passweg (Switzerland)
How to write a successful grant Robert Zeiser (Germany)
Introduction to medical statistics Simona Iacobelli (Italy)
Social media in stem cell transplantation and cellular therapy Navneet Majhail (United States)
Quality Management 09:15 - 17:30 On-Demand Library
QM5, Quality Management Oral Abstracts
Page 91 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Abstract 1
Abstract 2
Abstract 3
Abstract 4
Special Session 09:15 - 17:30 On-Demand Library
SS8, Social Media Session: Do's and don'ts of the interaction in the social media for the HSCT and cell therapy community
Social media beyond twitter for the HSCT and cell therapy community Navneet Majhail (United States)
Do's and don'ts of interaction in social media: Nurse's perspective Matthew Fowler (United Kingdom)
Do’s and don'ts of interaction in social media: How social media can improve patient outcomes - The patient's perspective Gillian Adams (United Kingdom)
Data Management 09:15 - 17:30 On-Demand Library
DM7, Education session 7
Minimal residual disease (MRD) Johannes Schetelig (Germany)
Special Session 09:15 - 17:30 On-Demand Library
SS9, How to get published
BMT: Official journal of the EBMT Hillard Lazarus (United States)
How to get published Mohamad Mohty (France)
Data Management 09:15 - 17:30 On-Demand Library
DM8, Education session 8
Page 92 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Infectious complications Malgorzata Mikulska (Italy)
Joint Session 09:15 - 17:30 On-Demand Library
JS4, Joint session LABMT
Transplant rates, Trends: WBMT/LABMT 2018 survey Oscar González-Ramella (Mexico)
Financing of HSCT in Latin America Gregorio Jaimovich (Argentina)
Selection, management and follow up of related donors: Overview Nina Worel (Austria)
Selection, management and follow up of related donors: Development of an LABMT consensus Gonzalo Ferini (Argentina)
Haploidentical transplants in Latin America: Experience from Argentina/GATMO in acute lymphoblastic leukemia Ana Basquiera (Argentina)
Haploidentical transplants in Latin America: Experience from Brazil/SBTMO in aplastic anemia Carmen Bonfim (Brazil)
Joint Session 09:15 - 17:30 On-Demand Library
JS5, Joint session WBMT: COVID-19 Vaccination in HSCT
Translating science into survival: mRNA vaccines for cancer and infectious disease Christopher Huber (Germany)
COVID-19 vaccination in HSCT Per Ljungman (Sweden)
Global access to COVID-19 vaccines
Working Party Session 09:15 - 17:30 On-Demand Library
IDWP, Infectious Diseases Working Party Session
IDWP update Rafael de la Cámara (Spain)
Page 93 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Current scientific proposals of IDWP Dina Averbuch (Israel)
CMV T-cell immunity monitoring: is it time to incorporate it in clinical practices? Roy Chemaly (United States)
What is new in the field of Gram-negative infections in SCT patients? Dina Averbuch (Israel)
Seasonal human coronaviruses vs SARS-CoV-2 in allogeneic hematopoietic stem cell transplantation Jose Luis Piñana (Spain)
Hepatitis C and hepatitis E in SCT Malgorzata Mikulska (Italy)
Central nervous system (CNS) complications following HSCT Martin Schmidt-Hieber (Germany)
Industry Symposium 09:15 - 17:30 On-Demand Library
IS38, CMV management in high-risk patients - Biotest Industry Symposium
Chairs: Fabio Ciceri (Italy)
A scoring system to define patients at high risk for CMV 09:15 - 09:25 Ibrahim Yakoub-Agha (France)
How to manage those CMV high-risk patients – Case Reports 09:25 - 09:35 Michele Malagola (Italy)
The immunological benefits of CMV-specific immunoglobulins 09:35 - 09:45 Javier Carbone (Italy)
Special Session 09:15 - 17:30 On-Demand Library
SS11, The EBMT for Trainees
Being a Trainee in SCT / Cellular Therapy Nico Gagelmann (Germany) Claire Horgan (United Kingdom) Yasmina Serroukh (Belgium) Yuliya Rogacheva (Russian Federation) Tamar Azikuri (Georgia)
Overview of allogeneic SCT for the trainee: ‘Things I wish I’d known' Helene Schoemans (Belgium)
Establishing a career in SCT/cellular therapy Jordan Gauthier (United States)
Page 94 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Complications for trainees 1: How to manage acute GVHD Zinaida Peric (Croatia)
Complications for trainees 2: How to manage VOD Ivan Moiseev (Russian Federation)
How do I … ? 09:15 - 17:30 On-Demand Library
HDI6, How Do I... manage toxicity in immunosuppressed patients?
Transplant associated TMA Sergio Giralt (United States)
Infectious complication Jan Styczynski (Poland)
Educational 11:00 - 12:15 Auditorium 1
E7, CARs in childhood malignancy
Chairs: Selim Corbacioglu (Germany) Jose M. Pérez Hurtado (Spain)
CAR therapies for lymphoid malignancies and beyond 11:00 - 11:15 Stephan Grupp (United States)
Adapter CAR T-cells: Implications for childhood cancer 11:15 - 11:30 Patrick Schlegel (Australia)
CAR NK-cells: The next generation of Cellular Cancer Therapy 11:30 - 11:45 May Daher (United States)
Q&A 11:45 - 12:15
Workshop 11:00 - 12:15 Auditorium 2
W6, Pretransplant risk management for allogeneic HSCT recipients and donors
Chairs: Adrián Alegre (Spain) Maria Gilleece (United Kingdom)
Patient infectious risk factors: What they are and how to deal with them 11:00 - 11:15 Simone Cesaro (Italy)
Patient comorbidity and organ issues 11:15 - 11:30 Jaime Sanz Caballer (Spain)
Page 95 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Donor issues posing a risk for themselves or for patients 11:30 - 11:45 Nina Worel (Austria)
Q&A 11:45 - 12:15
Nurses Group 11:00 - 12:15 Auditorium 3
NG09, Research session
Chairs: Sarah Liptrott (Italy)
Hold on - A Swedish research study regarding support needs among 11:00 - 11:15 family caregivers in allo-HSCT Jeanette Winterling (Sweden)
Getting involved in research: The experience of the junior member of the 11:15 - 11:30 Research Committee Marta Canesi (Italy)
A publication from scratch: My experience as the Infectious Diseases 11:30 - 11:45 Working Party Nurse Iris Agreiter (Ireland)
EBMT Nurses Group guidelines for abstracts scoring: Development and 11:45 - 12:00 evaluation Isabel Salcedo (Spain)
Q&A 12:00 - 12:15 Hilda Mekelenkamp (Netherlands) Sandra Schoenfeld (Switzerland)
How do I … ? 11:00 - 12:15 Auditorium 4
HDI4, How do I... best select patients for CAR T therapies? - Supported through an unrestricted educational grant by BMS
Chairs: Alessandro Rambaldi (Italy)
For NHL 11:00 - 11:25 Peter Dreger (Germany)
For Myeloma 11:25 - 11:50
Q&A 11:50 - 12:15
Page 96 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Data Management 11:00 - 12:15 Auditorium 5
DM2, Education session 2 - Discussion forum - Med A Live session
Chairs: Helen Baldomero (Switzerland)
Discussion forum - Med A 11:00 - 11:45 Per Ljungman (Sweden) Bertram Glass (Germany) Johannes Schetelig (Germany)
Q&A 11:45 - 12:15
Multi-stakeholder Forum on Innovative Cellular Therapies 11:00 - 12:15 Auditorium 6
MSF2, Multi-stakeholder Forum on Innovative Cellular Therapies - Session 2
Chairs: Nicolaus Kröger (Germany) Anna Sureda (Spain)
EBMT Clinical Trials Office: Cell Therapy Data Capture 11:00 - 11:15 Marianne Mol (Netherlands)
EMA's Patient Registry Initiative 11:15 - 11:30 Xavier Kurz (Netherlands)
How are new cellular therapies being rolled out? 11:30 - 11:45 Ibrahim Yakoub-Agha (France)
Pricing and real-life access to CAR-T therapy in the USA 11:45 - 12:00 Inmaculada Hernández Delso (United States)
Q&A 12:00 - 12:15
Meet the Expert 12:15 - 13:15 Meet the Expert rooms
Meet the Expert sessions
Special Session 13:00 - 14:00 Auditorium 4
SS5, Health inequalities and equality, diversity and inclusion at EBMT
Chairs: Raffaella Greco (Italy) John Murray (United Kingdom)
Page 97 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Progress in ED&I at the EBMT 13:00 - 13:10 Ben Summerskill (United Kingdom)
What have we learned? 13:10 - 13:20 Silvia Montoto (United Kingdom)
Patient perspectives on health inequalities 13:20 - 13:30 Bregje Verhoeven (Netherlands)
Health inequalities in BMT – A personal journey 13:30 - 13:40 Soulaiman Elias (Syrian Arab Republic)
Q&A 13:40 - 14:00
Data Management 13:00 - 14:00 Auditorium 5
DM3, Education session 3 - Registry Upgrade and Data Collection news in the EBMT
Presentation 1 13:00 - 13:30 Bas Middelkoop (Netherlands)
Registry Upgrade and Data Collection news in the EBMT 13:30 - 13:50 Per Ljungman (Sweden)
Q&A 13:50 - 14:00
Patient Advocacy Sessions 13:00 - 14:00 Auditorium 6
PA1, Patient Advocacy: Gathering data and shaping the research via patient inputs
Chairs: Andrea Linke (Germany) Natacha Bolaños (Spain)
LC: Patient engagement: Core outcomes set definitions 13:00 - 13:20
A patient inititated study in autoimmune disease 13:20 - 13:40 Ellen Kramer (Netherlands)
Round table discussion 13:40 - 14:00
Plenary Session 14:30 - 15:45 Auditorium 1
P3, Patient Reported Outcomes - A new paradigm in HSCT
Chairs: Rafael Duarte (Spain) Helene Schoemans (Belgium) Nicolaus Kröger (Germany)
Page 98 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Do PRO predict HSCT outcome? 14:30 - 14:45 Bronwen Shaw (United States)
Optimizing the management of GVHD using PRO measures 14:45 - 15:00 Rubeta Matin (United Kingdom)
PRO in CAR T-cell therapy 15:00 - 15:15 Anna Barata (United States)
Integrating the patient in HSCT research projects 15:15 - 15:30 Linda Burns (United States)
Q&A 15:30 - 15:45
Workshop 14:30 - 15:45 Auditorium 2
W7, Controversies in patients with DLBCL
Chairs: Anna Sureda (Spain)
Anything better than R-CHOP for first-line therapy? 14:30 - 14:45 Umberto Vitolo (Italy)
Has HSCT come to an end in relapsed disease? 14:45 - 15:00
CAR-T cells in relapsed/refractory DLBCL and beyond 15:00 - 15:15 Alberto Mussetti (Spain)
Q&A 15:15 - 15:45
Nurses Group 14:30 - 15:45 Auditorium 3
NG10, Oral session 1: Abstracts finalists
Chairs: Isabel Salcedo (Spain)
Workshop 14:30 - 15:45 Auditorium 4
W8, When modern hematology and antiinfective drugs meet at CYP450
Chairs: Oliver Cornely (Germany) Juan Diego Vélez (Colombia)
Is it time TDM our recent hematologic advances? 14:30 - 14:45 Roger Brüggemann (Netherlands)
Page 99 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Crossroads of life-saving drugs – Antifungal prophylaxis and novel agents 14:45 - 15:00 in oncology Jannik Stemler (Germany)
Practical consequences of co-administration of life-saving drugs 15:00 - 15:15 Samir Agrawal (United Kingdom)
Q&A 15:15 - 15:45
Data Management 14:30 - 15:45 Auditorium 5
DM4, Education session 4 - Data Managers' Discussion Forum: Centres, Registries and Study Offices
Chairs: Helen Baldomero (Switzerland)
From computer to bed-side: improving patient care through data 14:30 - 14:45 collection Juana Schwartz Mota (Spain)
The BSBMTCT: The Role of National Registries in Data Management – The 14:45 - 15:00 UK Experience Julia Lee (United Kingdom)
The EBMT Study offices: Using EBMT Registry data 15:00 - 15:15 Steffie van der Werf (Netherlands)
Discussion forum - Being a data manager: Practical issues 15:15 - 15:40 Julia Lee (United Kingdom) Juana Schwartz Mota (Spain) Steffie van der Werf (Netherlands)
Closing speech and thanks 15:40 - 15:45 Shelley Hewerdine (United Kingdom)
Patient Advocacy Sessions 14:30 - 15:45 Auditorium 6
PA2, Patient Advocacy: Patient engagement in research: Pro, let’s talk about it
Chairs: Bregje Verhoeven (Netherlands) Guy Bouguet (France)
CAB concept and implementation - Key achievement form CAB program 14:30 - 14:42 Natacha Bolaños (Spain)
Presentation of a non-pro patient engagement researcher 14:42 - 14:54 Sam Salek (United Kingdom)
Presentation of a pro patient engagement researcher 14:54 - 15:06 Menachem Bitan (Israel)
Page 100 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
EMA point of view: Impact or not? 15:06 - 15:18 Xavier Kurz (Netherlands)
Round table discussion with all participants: Arguments on whether 15:18 - 15:45 patient involvement in research is needed and efficient Pushpendra Goswami (United Kingdom)
Plenary Session 16:15 - 17:30 Auditorium 1
P4, New developments in the field of CAR cell therapy
Chairs: Álvaro Urbano-Ispizua (Spain) Christian Chabannon (France)
CAR T cells to prevent antigen escape 16:15 - 16:30 Marcela Maus (United States)
Anti-CD123 CAR-T cells for plasmacytoid dendritic cell leukaemia 16:30 - 16:45 (BPDCN) Francine Garnache-Ottou (France)
CRISPR-Case to engineer CAR-T cells 16:45 - 17:00 Edward Stadtmauer (United States)
Q&A 17:00 - 17:30
Workshop 16:15 - 17:30 Auditorium 2
W9, HSCT for immune modulation of solid organ transplantation
Chairs: Petr Sedlacek (Czech Republic) Antonio Pérez-Martínez (Spain)
Basis and opportunities of HSCT as a tool to induce immunotolerance to 16:15 - 16:30 SOT Megan Sykes (United States)
HSCT to induce immunotolerance to lung transplantation 16:30 - 16:45 Paul Szabolcs (United States)
HSCT to induce immunotolerance to composite tissue transplantation 16:45 - 17:00 Sebastian Giebel (Poland)
Q&A 17:00 - 17:30
Page 101 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 16:15 - 17:30 Auditorium 3
NG11, Paediatric session
Chairs: Hilda Mekelenkamp (Netherlands) Teija Schröder (Finland)
Parent transplant decision making and good parent research 16:15 - 16:35 Pamela Hinds (United States)
eHealth, home care and self-management in paediatrics 16:35 - 16:55 Inger Kristensson Hallström (Sweden)
Gamified mobile health intervention Triumf to prevent psychological 16:55 - 17:15 problems and support behavior change: Learnings from a qualitative study among pediatric cancer patients Kadri Haljas (Estonia)
Q&A 17:15 - 17:30
Special Session 16:15 - 17:30 Auditorium 4
SS6, COVID 2
How do I … ? 16:15 - 17:30 Auditorium 5
HDI5, How Do I... manage stem cell mobilisation in special cases? - Supported through an unrestricted educational grant by Sanofi
Chairs: Nina Worel (Austria)
Mobilisation of healthy donors - Standard procedures and perspectives 16:15 - 16:40 Kristina Hölig (Germany)
Mobilisation in children 16:40 - 17:05 Claudia Del Fante (Italy)
Q&A 17:05 - 17:30
Joint Session 16:15 - 17:15 Auditorium 6
JS3, Joint session EHA
Page 102 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021
Scientific Programme
Nurses Group 17:30 - 18:00 Auditorium 3
NG12, Nurses Closing Session
Chairs: John Murray (United Kingdom) Klara Kabatova-Maxova (Czech Republic)
Best of the best: Abstract prizes 17:30 - 17:35 John Murray (United Kingdom)
Highlights from physician's sessions 17:35 - 17:50 Anna Sureda (Spain)
Presentation of Prague 2022 17:50 - 18:00 Klara Kabatova-Maxova (Czech Republic)
General 17:35 - 18:10 Auditorium 1
GS4, Closing Ceremony
Chairs: Nicolaus Kröger (Germany) Rafael Duarte (Spain)
Presentation of the Springer Nature Poster Awards 17:35 - 17:40 Nicolaus Kröger (Germany)
Congress President closing remarks 17:40 - 17:50 Rafael Duarte (Spain)
Local Co-Presidents for EBMT 2022 Prague: Welcome 17:50 - 18:00 Petr Sedlacek (Czech Republic) Pavel Jindra (Czech Republic)
EBMT President closing remarks 18:00 - 18:10 Nicolaus Kröger (Germany)
Page 103 / 103
Powered by TCPDF (www.tcpdf.org)